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Abstract 
Background: 
33 million people worldwide are infected with HIV, a complex disease that affects 
many of the processes involved in wound and fracture healing. There is little 
evidence available to guide acute management of open fractures in these patients 
and fears of acute and delayed sepsis often inhibit the use of surgical fixation, which 
may be the most effective way of achieving union. This study addresses the 
hypothesis that the presence of either HIV or advanced HIV (CD4 count <=350) 
leads to an increased risk of complications in patients with open fractures treated 
with surgical stabilization.  
South Africa has one of the highest rates of both HIV and high energy trauma in 
the world, so was deemed an appropriate place for the study of this interaction.  
 
Methods: 
This prospective observational study compared surgical fixation of open fractures 
in HIV positive and negative patients.  
133 patients with 135 open fractures fulfilled the inclusion criteria. 86 fractures 
were in HIV negative and 33 in HIV positive patients. The remaining 16 patients 
refused HIV tests. 12 HIV positive patients had advanced disease (CD4 <=350), 14 
had early disease (CD4 >350), 7 refused CD4 count testing. This cohort was three 
times larger (number of HIV positive patients) than any similar previously published 
study. 
There was no randomised allocation; the treatment of these patients was based 
on locally developed protocols and was dependent on; fracture type, location and the 
grade of wound. Patients were followed up either till union had been achieved or for 
6 months in tibia/femur fractures, and 3 months in other fractures. 
The primary outcome was acute wound infection, secondary outcomes tested 
were fracture union and pin site sepsis. 
The analysis of the binary nominal data was done using the Chi squared test. In 
cases where the expected value was less than 5, then the Fisher’s exact test was 
used. In the assessment of multiple potential risk factors, binary logistic regression 
was used. 
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Results: 
Analysis of background characteristics showed that HIV positive and negative 
populations were broadly similar with regard to demographics, injury type/location 
and grade of wound.  
In the analysis of the primary outcome, the risk of wound infection was marginally 
higher in patients without HIV (22%) as compared to patients with HIV (15%). This 
difference was small and did not reach statistical significance (n=135, Risk Ratio 0.7, 
p value 0.40). However, as hypothesized, the infection risk was higher in patients 
with advanced HIV (26%), compared to patients with early HIV (5%). The numbers, 
however, were small and  this did not reach statistical significance (n=33, Risk 
Ratio=4.8, P value= 0.12).  
Sub group analyses, conceived prior to the study, provided strong evidence that 
patients with Gustilo Anderson grade 1 injuries had a higher risk of wound infection 
in patients with advanced HIV than controls (HIV negative and early HIV) (n=46, Risk 
Ratio=6.3, P value =0.02). Of note, departmental guidelines meant that patients with 
grade 1 injury were not prioritised for theatre and had, on average, a delay of 3.5 
days to surgery. The average delay was similar in both HIV positive and negative 
groups. 
Analysis of the secondary outcome, nonunion, provided strong evidence that the 
risk of nonunion was higher in HIV positive than HIV negative patients (n=115, Risk  
Ratio=4.1, P value=0.04). Interestingly, the patients with advanced HIV had a slightly 
lower nonunion risk (13%) than patients with early HIV (20%). However the numbers 
were small and the difference was not statistically significant  (n=33, Risk Ratio=0.8, 
P value=1).  
The incidence of nonunion was not correlated with the presence of wound 
infection. 
The risk of mild pin site sepsis in fractures treated with external fixation was 
similar in both HIV positive (60%) and negative (67%) patients (n=31, Risk 
Ratio=0.9, P value=1). An increased risk of severe pin site sepsis was noted in 
patients with advanced HIV (50%), compared to controls (25%). Although the 
difference is large, the numbers are small and the difference was not statistically 
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significant (n=28, Risk Ratio=2, P value= 0.31).  It would require 160 patients to 
prove a difference of this size. 
 
Conclusions: 
Data from this study appears to dispute the conclusion of previous studies that 
suggest that all patients with HIV are at higher risk of wound infection, and therefore 
internal fixation should be considered with caution. In this study it was only the 
patients with advanced HIV that showed a small increase in the risk of wound 
infection. 
Based on this study the author suggests that early HIV should not be a 
contraindication to either internal or external fixation in open fractures, due to 
concerns of wound infection. However, advanced HIV should  continue to be 
considered a relative contraindication to internal fixation, until further data becomes 
available. 
Since this finding applied equally to grade 1 (Gustilo Anderson) injuries, the data 
suggests that any theatre delays in patients with advanced HIV may be detrimental 
to outcomes. This is contrary to published data that suggests that grade 1 injuries do 
not need to be prioritised.   
The data provides strong evidence that HIV leads to an increased risk of non 
unions. Interestingly, the risk of non union is less in patients with advanced HIV. This 
may fit with recently published laboratory studies suggesting that the absence of 
lymphocytes is beneficial to bone healing. 
Based on this evidence the author suggests that in patients with HIV treatment 
strategies should be aimed at achieving union, rather than on potentially unfounded 
concerns of preventing infection.    
In patients treated with external fixation, the data provides weak evidence of an 
increased risk of severe pin site sepsis in advanced HIV. This observation may be 
due to an increased susceptibility to infection, or to problems with bone healing in 
these patients.  
Based on this evidence, and the evidence that patients with HIV may be at 
increased risk of non union, the author suggests that HIV positive patients being 
treated with external fixators, should be considered for treatment strategies that will 
8 
 
prolong the life of the pin bone interface. These may include additional pins, wires 
and/or the use of hydroxyapatite coated half pins. 
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Chapter 1 
Introduction 
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1 Introduction 
1.1 Purpose of the study 
 
The management of open fractures and the prevention of infection remains a 
challenging and controversial area in orthopaedics. Gustilo et al in 1976 published a 
paper which has been very influential in guiding the management of these patients1. 
However despite much research over the last 30 years, the optimal management 
remains uncertain and practice varies. In 2009 the British Orthopaedic Association 
and the British Association of Plastic, Reconstructive and Aesthetic Surgeons 
attempted to increase the standard of care by producing guidelines for the 
management of open fractures of the lower limb. These were based on evidence and 
where evidence was lacking, on expert opinion2. These guidelines have not 
addressed how patients who are immunosuppressed should be treated. 
Clinical studies looking at Human Immunodeficiency Virus (HIV) have shown  
high rates of wound sepsis in internally fixed open fractures as well as high rates of 
pin site sepsis in externally fixed fractures3-6, however these studies have lacked 
statistical power7. 
Laboratory based studies have shown that HIV infects a variety of cells including 
lymphocytes and macrophages. Once infected these cells become dysfunctional and 
may undergo apoptosis8. Subgroups of these cells are known to be important for 
initiating and regulating wound9 and bone healing10-12 and in the immune response to 
bacterial infection13,14.   
The increased availability of Highly Active Anti Retroviral Therapy  (HAART) has 
had a dramatic effect on the life expectancy of patients with HIV15,16. HIV remains an 
incurable disease and this is thought to be due to the presence of reservoirs of the 
virus within certain cell lineages, which are resistant to treatment17. Macrophages 
have been shown to be one such reservoir, and it is likely that these cells remain 
chronically dysfunctional even after the initation of HAART17.  Several studies have 
also suggested that Protease Inhibitors, a category of drug often used within the 
HAART regime, may directly affect bone metabolism and fracture healing18,19. There 
is however a paucity of clinical trials addressing these issues. 
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This study addresses the hypothesis that the presence of either HIV or advanced 
HIV (CD4 count <=350) leads to an increased risk of complications in patients with 
open fractures treated with surgical stabilization.  
This introduction aims to: 
Review the literature regarding wound infection and non union in open fractures.  
Review the literature regarding HIV and HAART with respect to surgical 
procedures, fracture healing and wound infection. 
Review the theories postulated for HIV’s interaction with wound and bone healing. 
The literature search was done using Medline,  Old Medline, Pubmed, Google 
Scholar: search strings used were: HIV, Human immunodeficiency virus, open 
fracture, prophylactic antibiotics, non union, wound infection, classification, internal 
fixation and external fixation. All relevant articles were reviewed if in English, and the 
full text acquired. Non English language article abstracts were reviewed, and their 
content noted. Experts in the field working with in the field of HIV and fracture 
healing were contacted and details of current research work was discussed  
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1.2 Open Fractures 
 
In 1850 a study at St Thomas’ Hospital of 362 patients suffering from compound 
fractures found that there was a risk of mortality of 33% in these patients20. The 
development of differing methods of internal fixation and soft tissue coverage along 
with improvements in antibiotic protocols has greatly reduced morbidity and mortality 
and increased rates of union. However with increasing use of internal fixation there 
have been concerns of increasing risk of deep implant associated infection21. 
 Concerns regarding internal fixation in open fractures are predominantly due to 
the difficulty of treating infections once established. This is commonly due to 
adherence of bacteria onto the implant and the presence of a biofilm which is 
impermeable to most antibiotics22,23. Over the last 60 years many factors have been 
identified as possible risk factors for infection through laboratory and clinical trials. 
The conclusions of these trials have often differed. Clinical differences between the 
study populations often make the trials incomparable. Fracture patterns and soft 
tissue injuries and treatments are very variable and difficult to classify accurately. 
Host factors such as nutrition and smoking which may be extremely relevant have 
often not been recorded. 
In 1946 Nicoll24, looked at a large series of open tibia fractures from South African 
miners, he concluded that the rates of non-union were dependant on the character of 
the initial injury, the most important factors of which were the initial displacement, the 
comminution, the soft tissue envelope, and the presence of infection. Subsequent 
papers have backed up Nicoll’s astute observations, however it was not until 1976 
when Gustilo and Anderson developed a classification system that there was some 
consensus within the literature on how to grade these injuries 1. Prior to this paper, 
clinical trials looking at open fractures are extremely difficult to assess and compare 
because of the variability of recorded data. A review of these grading systems and 
subsequent developments is given below.  
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1.2.1 Grading systems 
 Nicoll 1.2.1.1
The  classification system developed by Nicoll in 1964 was based on a study of 
705 tibia fractures of which 144 were open sustained  in both South Africa and the 
UK24. The injuries were classified by wound (W), comminution (C) and displacement 
(D), and were graded either, nil/slight (N), or moderate/severe (S). Rates of non 
union in the cohort were then calculated. These are given in Table 1-1. 
 
Table 1-1 
Fracture type Rates of 
Delayed/Non union 
(%) 
ND NC NW 9 
ND NC SW 12 
ND SC NW 15 
SD NC NW 27 
ND SC SW 39 
SD NC SW 55 
SD SC NW 31 
SD SC SW 39 
 
In developing this classification system Nicoll had identified some of the key 
aspects of the character of a fracture which have been subsequently elaborated on 
by other authors 
 Gustilo and Anderson 1.2.1.2
 
The Gustilo and Anderson classification introduced in 1976 looked at a series of 
1025 open tibia fractures. It was amended in 1984 following a series of 75 grade 3 
open fractures. It is still the most widely used classification today 1,25. Table 1-2 
summarizes the Gustilo Anderson classification and gives approximate infection 
rates. 
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Table 1-2 
Grade Approximate 
Infection rate 
Description 
1 0% Low energy. Small soft tissue defect <1cm 
2 3% Low energy. Skin laceration <10cm with 
minimal soft tissue damage 
3a 4% Adequate soft tissue coverage of the fractured 
bone despite extensive soft tissue laceration, 
flaps, or high energy trauma, irrespective of 
the size of the wound. 
3b 52% Extensive soft tissue loss with periosteal 
stripping and bone exposure. 
3c 42% Arterial injury requiring repair 
 
Even this classification system has been shown to have high inter-observer 
variation26,27.  Subsequent authors have tried to produce extended classification 
systems to try to classify more accurately the soft tissue injury and host factors.  
 Arbeitsgemeinschaft für Osteosynthesefragen 1.2.1.3
(AO) Classification 
 
In 1983 Tscherne et al28 described a grading system for  soft tissue injury. This 
system has subsequently been incorporated into the Hanover fracture scale. This is 
a detailed scoring system taking into account multiple aspects of the injury and is 
used as part of the AO classification. This classification can be used to describe both 
open and closed injuries but does not take into account patient co-morbidities. 
 Host classification 1.2.1.4
 
In 2005  Bowen et al29 described the Host classification to help predict outcome in 
patients with significant co-morbidities. This was based on a retrospective study of 
174 long-bone fractures. Their grading system is derived from a system looking at 
adult osteomyelitis which was developed in 1985. This system was then refined for 
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looking at periprosthetic total hip infection. The patients were divided into three 
classes based on the presence or absence of fourteen medical and immune-
compromising factors. These included: an age of eighty years or more; current 
nicotine use; diabetes; malignant disease; pulmonary insufficiency; and systemic 
immunodeficiency (HIV). Patients were categorized as having 0, 1-2 or >3 risk 
factors. A CD4 count of less than 200 cells/µL, (a mark of advanced HIV disease or 
Acquired immune deficiency syndrome (AIDS)) automatically places the patient in 
the final group.  
Although this grading system appears to correlate with infection, it takes a lot of 
variables into account, many of which have not been validated individually.  
Of particular relevance to HIV infection is that this classification system may be 
used to guide clinical decision making. It may lead to patients being inappropriately 
treated if for example they are deprived of the method of fixation of a fracture that is 
optimal for achieving union.  
 Ganga Hospital score 1.2.1.5
 
This scoring system published in 2007, is an extensive scoring system based on 
the experience of a large trauma and reconstruction unit in India30. It takes into 
account a variety of factors, including soft tissue and skin damage, as well as co-
morbidities including diabetes and age greater than 65 years. It has been used as 
tool to give an indication of outcome, and to guide management as part of a 
management protocol.  
This new scoring system has yet to gain widespread popularity, and there has 
been some concern as to the emphasis that is placed on the need for debridement 
within 12 hours which is not felt to be evidence based31.  
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 Gunshot wounds (GSW) 1.2.1.6
 
GSW, of which there were significant numbers in the series to be reported, pose 
certain problems in classification. 
Gusitllo et al1 in 1976 classified all GSW as grade 3 injuries. In their paper, it was 
stated that the management for this type of injury should be debridement, irrigation, 
and avoidance of internal fixation. Subsequently in 1984 Gustilo et al25 implied, but 
did not clearly state, that it is only high energy GSW that should be categorized as 
grade 3.  
Barach et al32 reviewed the mechanism with which a bullet causes injury and 
found it has more to do with tissue-bullet interaction than purely bullet velocity. The 
authors concluded that it is possible for a low energy missile to cause tissue 
destruction normally characterised by a high energy missile. 
Long et al33 noted that most patients in the civilian setting are unable to describe 
the type of weapon they were shot with. They have developed a classification 
system based on the distal femur and looking at the clinical features of the wound to 
give guidance on management. They also noted that high energy missiles generally 
result in larger wounds. 
Infection following GSW has long been a problem.  John Hunter in 179434 
described how the projectile can carry debris from the surrounding area into a 
wound.  GSW from both low and high energy bullets are not generally sterile. It has 
been shown that a low energy bullet is not sterile when it penetrates the skin and 
that the negative pressure associated with the bullet trajectory sucks debris and 
fragments of clothing into the wound35. 
 Management of these injuries has been controversial. John Hunter was an early 
advocate of conservative management, whilst many of his colleagues were 
advocating aggressive debridement and early amputation34. More recent studies are 
again suggesting that many GSW can be treated non operatively36-39 and with oral 
antibiotics37.   
Some papers are now advocating that patients with small wounds, and fractures 
not requiring fixation, can be managed as an outpatient 37,39. An exception to the 
above management is if there is any possibility of the bullet or fragment of a bullet 
being within a joint when it would require urgent debridement and removal of that 
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fragment. This is due to the possibility of lead toxicity40, and also due to a foreign 
body interfering with the mechanics of the joint 
The above controversy has led to discrepancies over whether a GSW should be 
classified as a grade 3 wound, as Gustilo et al initially suggested, or according to the 
size of the wound or the energy of the trajectory. 
 Conclusions 1.2.1.7
 
Despite the development of different grading systems, the Gustilo Anderson 
classification remains the most widely used in clinical trials and therefore is the 
classification utilized in this thesis.  
In this study GSW have been graded by the size of the wound in the same way 
as for the other method of injuries. 
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1.2.2 Debridement in open fractures 
 
The need for urgent debridement in open fractures is currently controversial. 
Historically priority has been placed on getting patients with open fractures to theatre 
within six hours for debridement. The evidence base for this originated in 1898 with 
research done on guinea pigs41. Subsequent authors such as Gustilo et al, 
advocated emergency debridement for optimal results1. However in a review on the 
subject, Crowley et al42, showed that only one out of nine papers published in the 
last 30 years showed a reduction in the risk of wound infection in patients who went 
to theatre in less than 6 hours. In a review of the literature and consensus of expert 
opinion the British orthopaedic association now recommend that debridement is 
performed on a day time list, with senior/experienced surgeons operating43. 
Grade 1 injuries are also controversial. Recent evidence suggests that infection 
rates in Grade 1 injuries remain low with or without debridement, provided early 
antibiotics are administered44. Low energy gun shot wounds which are often 
classified as Grade 1 injuries also do well without operative debridement. One trial 
showed that if the fracture did not require operative intervention then these patients 
could be managed as an outpatient with oral antibiotics37. 
1.2.3 Stabilization in open fractures  
 
In a retrospective review of patients from 1955-1968, Gustilo et al1 looked at 
infection rates in open femur and tibia fractures treated either conservatively or 
operatively. In this initial paper the fractures were not graded, and the treatment was 
dependent on surgeon preference. In a comparison of the 52 fractures treated with 
internal fixation versus the controls treated with traction or plaster of paris (POP) 
immobilization they noted infection rates of 19% and 5% respectively.  On the basis 
of this evidence they concluded that internal fixation in open fractures should not be 
used, except where it is essential due to arterial injury, or where soft tissue damage 
makes it impossible to manage the fracture by other means.  
At about the same time McLaughlin et al45  hypothesized that the constant small 
movements seen in conservatively managed fractures may lead to further tissue 
damage and increase the risk of infection. This was further investigated by Worlock 
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et al46 using an experimental animal model looking at the role of stability and 
infection in open tibia fractures. They found that the rate of osteomyelitis was 50% 
higher in animals treated with unstable fixation rather than stable fixation, concluding 
that stable fixation aided revascularization of bone and soft tissue, hence reducing 
the infection rate. 
1.2.4 Internal fixation effects on cortical blood supply 
 
Cortical blood supply is thought critical for both bone healing and prevention of 
wound infection. Cortical blood supply comes from three sources as shown by 
Rhinlander in Figure 1-147.  
The Nutrient artery  
Periosteal arteries 
The Medullary artery (via the Metaphyseal arteries) 
 
There has been concern regarding internal fixation of fractures and how it may 
affect the cortical blood supply. In1968 an animal model showed that dynamic 
compression plates (DCP) plates lead to devascularisation of up to half of the 
cortical width in areas with contact with the plate. This is thought to be due to 
damage to the Periosteal arterioles48,49. These findings led to the development of 
limited contact  dynamic compression plates(LCDCP), a 50% reduction in the 
contact area50 and more recently to Point Contact locking plates (PCfix). The 
advantage of the PC fix plates is twofold in that there is reduced metal to bone 
 
Figure 1-1: Blood supply of a long bone 
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contact and its insertion requires less periosteal stripping, as it does not need to be 
placed directly on the bone,  and hence helps preserve the blood supply. 51. The PC 
Fix technique appears to increase the inoculum required to cause infection 
approximately twelve times as compared to conventional DCP plate52. 
With the development of locked intramedullary nails, it became possible to obtain 
relatively stable fixation using an intramedullary device. There have been concerns 
over how this may affect cortical blood supply via the medullary artery, especially 
when reaming is employed. Schemitsch et al53 looked at blood flow in fractures of 
sheep’s tibiae treated by either reamed or unreamed nails and showed a significant 
decrease in cortical perfusion in both groups. The reamed group was significantly 
more affected. Revascularization took up to 12 weeks in the reamed group and 8 
weeks in the unreamed group. This loss of medullary circulation is of particular 
concern in open fractures where soft tissue damage may also have damaged the 
periosteal blood supply. Damage to both periosteal and medullary blood supply may 
render the fracture-site ischemic. 
In  2000, a meta-analysis54 looked at stabilization of open tibia shaft fractures with 
intramedullary nails. This analysis was unable to identify any significant difference in 
outcome between reamed and unreamed nails.  
HIV has been shown to be related to macro and micro vascular disease55. How 
this may affect cortical blood supply has not been studied and maybe a relevant 
factor related to the devascularisation of the bone cortex by internal fixation. 
1.2.5 External fixation 
 
External fixation has historically been advocated for obtaining bone stability in 
severe open fractures of the tibia25,56-58. This is because it is thought to affect cortical 
blood supply in the vicinity of the fracture less than either plate fixation or 
intramedullary fixation .It avoids placing metal work directly around the fracture site, 
and it is also simple to remove/resite should infection occur. The presence and 
position of the fixator can however prove difficult with wound management, both with 
respect to dressings and flaps. The development of unreamed nails and reduced-
contact locking plates have led to the advantages of minimizing disruption to the 
cortical blood supply and improving  access to the soft tissue59. External fixators 
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have the advantage over locking plates and intramedullary devices, in that relative 
stability can be provided initially, but the fracture can then be manipulate to improve 
the position or provide stimulation for bone healing. External fixators can also be 
adjusted postoperatively to provide optimal alignment. Pin tract infection can be a 
problem in the use of external fixators, however, with careful follow up, the use of 
occlusive foam dressings, wound hygiene and appropriate antibiotics this can 
normally be addressed.  
1.2.6 Internal or External fixation for Tibia fractures? 
 
The choice between internal or external fixation for open tibia fractures is 
controversial. A recent meta analysis looking at reamed and unreamed nailing 
against external fixation of open tibia fractures, shows a significantly reduced 
reoperation rate in the patients treated with nailing54. However the use of nails 
remains debated in certain situations. Grade 3b tibia fractures requiring free flaps 
have recently been shown to have higher rates of osteomyelitis and non-union if 
treated with nailing rather than an external fixator60. Many surgeons will use a 
combination of the evidence available in the literature and their own personal 
experience and inclination when deciding whether to nail or external fix open tibia 
fractures. 
1.2.7 Bacterial adherence and the formation of the 
Biofilm 
 
Adherence of bacteria to metallic implants is an important factor in foreign body 
infection. It is also a prerequisite for the formation of biofilms 22. Staphylococcal 
aureus (S.aureus) and Staphylococcal epidermidis (S.epidermidis) are the two most 
important bacteria involved with foreign body infection. Several studies have shown 
that S.aureus has an affinity for metallic implants, whereas S.epidermidis is more 
commonly seen in polymer-based implants61,62.  The two most commonly used 
implant materials in fracture fixation are stainless steel and titanium. In studies using 
animal models titanium showed a lower susceptibility to infection over stainless steel, 
requiring approximately 10 times the inoculum to cause similar rates of infection.52,63 
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Initially bacteria adhere to the prosthesis. These bacteria then synthesize an 
extracellular polymeric substance and form into microcolonies64. During the 
formation of a biofilm, attached bacterial cells release antigens and stimulate the 
production of antibodies thereby attracting phagocytes. In response, phagocytes 
release enzymes, which are not able to completely destroy the biofilm but instead 
may damage the surrounding host tissue. As the bacterial colonies mature, surface-
associated, non growing (dormant) bacteria on the periphery detach and disperse as 
suspended, active bacteria that can multiply rapidly. 
The dormant bacteria within the biofilm exhibit marked antibiotic resistance 
compared to the surface (active) bacteria. Several theories for this have been 
postulated: 
Bacteria in biofilms are enclosed within a negatively charged matrix that can 
physically restrict the diffusion of large molecules, such as some antimicrobial 
agents, enzymes, and complement components65. 
Nutrient depletion or waste-product accumulation within the biofilm causes some 
bacteria to enter a dormant state in which they are less susceptible to growth-
dependent antimicrobial killing66 
How HIV affects the biofilm formation, and how increasing immunosupression 
affects the balance between dormant and active bacteria is as yet unknown but may 
be a potential source of delayed sepsis. 
1.2.8 Early primary closure of wound 
 
It is now accepted that the organisms leading to infection in open fractures, are 
predominantly hospital acquired21,67 rather than from contamination present in the 
wound at the time of injury. The traditional teaching has been to leave wounds open 
for at least 48 hours to allow suppuration before considering closure at that stage if 
they still appear clean, with prophylactic antibiotic cover25. It has been speculated 
that if an adequate and early debridement has been carried out, it may be possible to 
close the skin primarily, and hence reduce the access of  nosocomial organisms to 
the fracture site67. Rajasekaran et al68 looked at 557 carefully selected grade 3a 
open fractures which they closed primarily on initial debridement. They observed 
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excellent outcomes in 87% of patients with only 5 patients developing deep 
infections (<1%). This paper may signal a dramatic shift in the management of these 
fractures towards early wound closure.  
1.2.9 Risk factors for wound infection/fracture union 
 
Host factors affecting healing have been well studied. There is some evidence to 
suggest that fracture healing is inhibited in the elderly and that this is exacerbated by 
difficulty in obtaining solid internal fixation in osteoporotic bone69,70. 
Both animal and clinical trials have shown that diabetes affects fracture healing. 
In untreated diabetes, it appears that the callus contains significantly less collagen 
and DNA and that this is associated with decreased strength and stiffness of the 
fracture repair. Good diabetic control seems to at least partially-alleviate these 
issues71,72.  Significantly longer time to union, and increased incidence of non-union 
is also seen in these patients73 
Iron deficiency anaemia has been shown to lead to significant deficiencies on 
bone healing in rats. This is thought to be due to a reduction in the delivery of 
oxygen to the tissues, but also due to a reduction of iron, which is critical in the 
electron transport system and the formation of collagen. 
It has been shown that nutrition is important in fracture healing. An albumin below 
35 grams per litre in trauma patients has been shown to be associated with longer 
inpatient stay, higher mortality and worse functional outcome74. Vitamin and mineral 
deficiency is also thought to be important. Deficiencies in vitamins C,B6, D, 
phosphorous and calcium have all been shown to have a negative effect of bone 
healing75. 
Studies have shown that smoking affects wound and bone healing. The exact 
mechanism is not understood, but it is thought not to be dependent on nicotine76.  
Clinical trials have shown smokers to have a significantly longer time to union in tibia 
fractures77. Another study showed smokers to be one third more likely to develop 
non-union and twice as likely to develop infection78. 
Alcohol abuse has been shown to be a significant causative factor for trauma, 
and is also implicated in fracture healing79. The effect of alcohol on bone healing is 
thought to be a dose-dependent effect on osteoblast activity, this results in a callus 
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that is not as stiff, has decreased strength and reduced mineral content compared to 
controls80 
Several orthopaedic trials into open fractures have used wound infection as an 
outcome measure1,3.  The definition of wound infection can be variable from study to 
study, and may include mild signs of infection which settle rapidly with antibiotics. 
One study showed that superficial wound infection was not a significant risk factor for 
subsequent deep infection81. Superficial wound infection should perhaps be 
considered a risk factor rather than an outcome measure in these studies.  
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1.2.10 Prophylactic Antibiotics 
 
The first account of infection control in open fractures in the literature appears to 
have been in 1867, when Lister treated open fractures with carbolic acid82. This 
concept evolved out of observing the effect carbonic acid had on Glaswegian 
sewage!  The use of prophylactic antibiotics in open fractures has now been shown 
to be beneficial however, how they are used remains controversial83. The two main 
trauma societies in the United States have recently updated their guidelines. They 
both comment on the paucity of recent good quality evidence and as a result there 
are some differences in their advice84,85. 
The concept of prophylactic antibiotics in open fractures is complicated and is 
often misunderstood. In contaminated wounds, bacteria that are inoculated into the 
wound are rarely the bacteria that go on to cause sepsis86-89. High numbers of 
bacteria at the time of initial debridement may reflect localized immunosupression, 
due to injured or devitalised tissue which may then be vulnerable to nosocomial 
infection.11,90,91  
Culture of wound infections in patients following open fractures appears to show 
higher rates of resistance to prophylactic antibiotics and also higher rates of MRSA 
infection86. There is also concern that these patients are at risk of developing 
antibiotic resistance to other systemic infections (e.g. Lower respiratory tract 
infections) secondary to extended prophylactic antibiotic use.  
The choice of antibiotic is also debated. In a review of the literature, Hauser et 
al85, concluded that an anti staphylococcal agent such as a first generation 
cephalosporin would be an effective prophylactic choice in open fractures. The use 
of aminoglycosides for grade 3 open fractures is more controversial. Work by 
Patzakis et al83,92, looking into wound infections in open fractures, found that many of 
the infecting organisms in the grade 3 injuries were Gram negative. He concluded 
that we should therefore include gram negative cover in our prophylactic regime of 
these fractures.  
There are however many trials, showing no improvement in infection rates by 
adding Gram negative cover in these injuries83,86,93-95. There is also concern that 
including  Gram negative cover at the prophylactic stage will only increase the speed 
with which antibiotic resistance develops85 
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A Randomized Control Trial (RCT) has shown that a twenty four hour course is as 
effective as a five day course of prophylactic antibiotics in penetrating abdominal 
trauma 96 . Dellinger et al looked at prophylactic antibiotic use in open fractures and 
showed that a one day course of a 2nd generation cephalosporin to be as effective as 
a five day course in preventing wound sepsis in a double blind RCT93. On the basis 
of this work the American guidelines are now suggesting a 24 hour prophylactic 
antibiotic protocol in open fractures 85. 
The recent British Orthopaedic Association (BOA)/ British Association of Plastic, 
Reconstructive and Aesthetic Surgeons (BAPRAS) guidelines have struggled to 
incorporate the current evidence on antibiotic usage with the concern over inducing 
Clostridium difficile infection as a result of their use43. They have therefore modified 
the antibiotic recommendations using microbiological principles, without an evidence 
base, and are suggesting Co-amoxiclav as an antibiotic which has a similar 
spectrum of activity, but may have a reduced incidence of Clostridium difficile 
associated diarrhoea. 
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1.3 HIV 
1.3.1 Background 
 
HIV is a member of the retrovirus family that leads to acquired immune deficiency 
syndrome (AIDS). It is a blood borne virus that is transmitted via blood, semen, 
vaginal fluid, or breast milk. It was first observed clinically in 1980, but it was not 
formally identified until 198497. 
There are 2 main types of the HIV virus.  HIV-1 is thought to have jumped species 
from the common chimpanzee, and HIV-2  which is thought to have come from the 
Sooty Mangabey monkey. HIV-2 is confined to West Africa, and is not responsible 
for the HIV pandemic. HIV-1 is further divided into subtypes, which are geographical 
distributed as in Figure 1-298. 
  
Sub types although grossly similar do show individual characteristics, especially 
with regard to response to HAART98. The European and North American sub type is 
different to that found in Southern Africa. 
HIV infects 3 main cell lineages, CD4-T cells, macrophages, and dendritic 
cells. Whilst infected T cells tend to undergo apoptosis, the other cell types tend to 
 
Figure 1-2 . Geographical distribution of HIV-1 sub types.  Letters 
indicate the predominant HIV-1 sub type circulating in selected countries. 
A/B, B/E, and B/F indicate co-circulation of two dominant sub types; AE 
and AG indicates circulating recombinant forms.  
 
 
28 
 
remain chronically infected99. As infection progresses the number of CD4 -T cells 
detected in the blood decreases, this can be used as a marker of disease severity. 
The number of viral particles in the peripheral blood is a marker of viral replication, 
and again this can be measured (viral load), and gives an indication of the likely rate 
of disease progression. Viral load is often used to monitor for treatment failure as 
controlling the replication of the virus is the mainstay of treatment 100. Financially CD4 
counts are cheaper at approximately $35 a test, whereas viral load costs 
approximately $60, this means in resource limited settings viral loads are rarely done  
101
. 
 
 Prevalence 1.3.1.1
 
Prevalence of HIV varies from country to country. Exact prevalence rates are 
difficult to determine because of the lack of universal testing. However estimates are 
made using specific cohorts of patients such as rates obtained from antenatal care 
and emergency admissions. Globally 33.2 million people were estimated to be living 
with HIV in 2007102. Prevalence rates vary considerably by communities and regions. 
South Africa has the highest recorded rates in the world. Recent data from pregnant 
women in northern Kwazulu-Natal suggests a prevalence of around 38%103. In the 
UK the prevalence was estimated at 0.2 %104. Studies looking at patients admitted 
with major trauma to a Johannesburg Trauma unit showed an HIV point prevalence 
of 30%.105 
1.3.2 Highly-Active-Anti-Retroviral Therapy (HAART) 
 
Antiretroviral therapy (ART) for treatment of Human Immunodeficiency Virus type 
1 (HIV-1) infection has improved steadily since the advent of combination therapy in 
1996. Studies have shown a dramatic decrease in mortality 15,16,106 and in vertical 
and horizontal transmission107,108 in patients on ART. Development of the treatment 
guidelines have shown that patients need to be taking three different drugs in order 
to get a good response to treatment. This three drug regime has become known as 
HAART 109 however the individual drugs used in this treatment regime may vary. 
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Timing of the initiation of HAART has been controversial. Institutions consider 
starting treatment when the CD4 count is between 350-200 cells/µL 110. In countries 
where CD4 count is not available it is possible to start treatment depending on WHO 
clinical stage and total lymphocyte count.  
Once HAART is initiated, CD4 levels typically rise but they do not return to 
normal. Provided the patient continues the medication, and the virus remains 
susceptible, CD4 counts should remain high. On discontinuation of HAART CD4 
counts will return relatively quickly to their pre HAART levels and will then continue 
to decline111. 
Governments in Southern Africa have only recently started to distribute HAART 
freely as national programs, Botswana in 2001112, South Africa in 2003113 and Kenya 
in 2004114. In 2006 324,000 patients were taking HAART in South Africa, estimated 
to be approximately 21% of the patients who required it102.  
Several studies have suggested that HAART may interfere with bone 
metabolism19,115-118. It is however difficult to identify the causative factor, as HAART 
will always contain at least three drugs, but these vary between and within countries, 
and all patients will have HIV. Protease Inhibitors, one particular class of ARV’s, 
have been identified in several studies as a possible cause of osteoporosis19,118. 
However most studies have been cross sectional and therefore causation can not be 
inferred. In the few longitudinal studies conducted, osteoporosis rates are high in 
patients receiving HAART, but do not appear to progress, once patients have been 
on treatment for over a year.119,120.  
It is however currently not possible to eradicate completely the virus. The virus 
continues to infect many cells, particularly macrophages and dendrocytes, which are 
important mediators of the immune system, and intracellular signalling. It is therefore 
not possible to assume that once a patient is initiated on HAART, wound and 
fracture healing will return to normal. 
 Compliance 1.3.2.1
 
HIV viral suppression, reduced rates of resistance 121,122, and improved survival 
123, have been correlated with high rates of adherence to antiretroviral therapy 111. 
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The development of resistance to ARV’s is emerging as a major problem in the 
treatment of HIV. Poor compliance leads to higher risk of developing resistance. 
Most HAART regimes used in developing countries including in South Africa 
incorporate two Nucleoside Reverse Transcriptase Inhibitors (NRTI) and one Non-
Nucleoside Reverse Transcriptase Inhibitors (NNRTI). The use of Protease inhibitors 
(PI) is limited to cases that fail initial therapy. NNRTI regimes are particularly prone 
to developing resistance in cases of poor compliance. This is predominantly due to 
the long half-life of the NNRTI124. PI have been implicated in osteoporosis118. 
In the series reported in this thesis it was apparent that trauma patients often 
forget to bring their medication, fail to tell the medical staff that they are taking 
HAART, or are unable to take because of inability to tolerate oral medication leading 
to poor compliance whilst in hospital and the consequent risk of developing a 
resistant virus. 
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1.3.3 HIV and fracture management 
 
In 1987 shortly after HIV was discovered, the first paper linking HIV with 
orthopaedics was published in the Journal of Bone and Joint Surgery. It described  
an HIV positive patient presented with diffuse osteomyelitis (Mycrobacterium kansaii) 
which was resistant to treatment125. Most  of the subsequent research looking at HIV 
and surgical complications is based on observational, retrospective reviews, with 
small sample sizes and unmatched hospital controls126. Many of the conclusions 
from these studies need to be interpreted with caution.  
 Hoekman et al127 1.3.3.1
In 1991 Hoekman et al published a prospective study case control study looking 
at internal fixation of closed fractures, comparing wound infection rates of HIV 
negative patients, HIV positive and asymptomatic and HIV positive and symptomatic. 
This study utilized the CDC classification, and all grade 4 disease was classified as 
symptomatic. The study was conducted before the WHO grading system was 
developed and before CD4 counts were available. The patients received no 
prophylactic antibiotics and the outcome measure was wound infection with positive 
microbiology. They followed their patients up for a minimum of 12 months. They had 
174 patients who were HIV negative, 26 patients who were HIV positive but 
asymptomatic, and 17 patients who were HIV positive and symptomatic. There 
results are summarized in Table 1-3. 
Table 1-3. 
Group Infection rate Risk of developing infection 
compared to HIV negative cohort 
HIV negative 8/174 (5%)  
HIV positive and 
asymptomatic 
0/26 (0%) RR= 0, p value 0.6FE 
HIV positive and 
symptomatic 
4/17 (24%) RR = 1.39, p value 0.01FE 
 
32 
 
 
All infections in the symptomatic HIV group settled on antibiotics with out the 
requirement for metal work removal. 
This data provided good evidence that the risk of infection was higher in patients 
with advanced (symptomatic) disease, however the data did not suggest that this 
should alter the management in this group of patients as they all did well with 
conservative treatment 
 Obrien et al128 1.3.3.2
In 1994 O’Brien et al published a study from New York where they looked at 15 
open fractures of the tibia, 3 of the 14 patients were HIV positive128. They were all 
managed using the same protocol and HIV did not affect management. All of the HIV 
positive patients developed wound infection, and two of them developed 
osteomyelitis. On the basis of this it summarized that HIV adversely affects outcome, 
and treatment algorithms should account for this. 
 Jellis4 1.3.3.3
In 1996 Jellis reported his results of a retrospective case series in Zambia as part 
of a review of HIV and Orthopaedic surgery. His series included a total of 44 HIV 
positive patients with fractures. His data does not specify how this is broken down 
into patients with open/closed injuries, or patients treated either operatively or non-
operatively and did not include any HIV negative controls.  
 His results showed that closed fractures, treated conservatively, healed without 
complications. However of the patients treated with internal fixation 33% developed 
infection. Open fractures fared even worse with a 72% infection rate and a 28% non 
union rate, the method of fixation is also not mentioned. 
These results need to be treated cautiously due to the lack of controls, and lack of 
any statistical analysis. It is however an often quoted paper, and has added weight to 
the concern over treating open fractures with internal fixation. 
 Harrison et al3 1.3.3.4
 
In 2002 Harrison et al conducted a single blinded prospective study looking at 
wound infections in HIV positive patients treated by internal fixation with both open 
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and closed fractures in Malawi. Patients treated with external fixation were excluded, 
the management protocols are not described and it is possible that patients with HIV 
may have been more readily treated with external fixation. This would have lead to a 
significant selection bias. In their series, open fractures were defined as including 
fractures with significant abrasions, repeat surgery for non union of a previously 
open fracture, or patients who had ever had previous surgery at the same site 
before. All patients received prophylactic antibiotics (1st generation cefalosporin). 
They used the ASEPSIS scoring system129 to define infection which attempted to 
give some objectivity to their findings and had one surgeon scoring all the wounds to 
give consistency. They had follow up data for three months with only a 6% loss to 
follow up Their results are summarized in 
Table 1-4: 
Table 1-4 Summary of results from Harrison et al 
3
 study looking at wound infection in HIV 
positive and negative  patients following internal fixation of fractures 
Closed fractures 
 (%) Infection No Infection  
HIV positive 1 (4) 27 (96) P value
FE
 = 0.28 
HIV negative 6 (6) 102 (94) RR = 3.6 (0.5-24.5) 
95%CI
 
Open fractures  
(%) Infection No Infection  
HIV positive 5 (42) 7 (58) P value
FE
 = 0.08 
HIV negative 3 (11) 24 (89) RR = 3.75 (1.1-13.2)
 95%CI
 
 
Of the patients who developed infections three of the five HIV positive patients 
were having operations for previous non-unions, whereas the HIV negative patients 
were all undergoing primary plating. This suggests the study group and the control 
may not have been comparable, possibly due to selection bias as a result of higher 
non union rates in HIV positive patients.  
These results suggest there is little evidence of an association between HIV and 
infection rates in closed injuries. There was a fourfold increase in risk of superficial 
wound sepsis in open fractures but weak evidence that this finding was not due to 
chance alone.  
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 Harrison et al130 1.3.3.5
 In 2004 Harrison et al published a prospective blinded series of 27 severe open 
tibia fractures Gustillo Anderson grade 2 and 3 of which 7 were HIV positive, looking 
at wound infection. Patients were all managed initially with a monolateral exfix till the 
soft tissues had healed or were at least stable. The frame was then removed and the 
fracture managed till union in the plaster. HIV did not affect management. The 
outcomes were the wound scores measured by the ASPESIS scoring system and 
Checketts pin score and bony union. They showed a significantly higher rate of 
sepsis in the wounds and a higher rate of non union although this was not significant 
in the HIV positive group, the data also suggested a slower rate of fracture healing in 
these patients. They acknowledge that the management of their patients was 
unusual but it was the method that worked best in the limited resource setting.  
 Harrison et al131 1.3.3.6
In 2004 Harrison et al also published the 1 year follow up of a group of 36 HIV 
positive patients who had undergone implant surgery for closed fractures, non 
unions or joint arthroplasties. At 1 year no implants had developed deep infections to 
the author’s knowledge although 8 patients were lost to follow up and 2 died of 
causes unrelated to their implant. This study suggests that in clean orthopaedic 
implant surgery the risk of delayed sepsis at 1 year is minimal. 
 
 Norrish et al6 1.3.3.7
 
In 2007 Norrish et al conducted a single blinded prospective cohort study looking 
at pin site infections in open fractures treated by external fixation. They had selection 
criteria of tibia fractures that were grade 2 or more and were suitable for external 
fixation, with both the surgeon and the wound assessor blinded to HIV status. They 
attempted to make the scoring system objective using the Checkett’s pin site scoring 
system and they scored pin sites individually, so each patient had six data entries. 
They did not look at union rates. 
They study looked at 15 HIV positive patients and 35 HIV negative patients. In the 
whole study only 1 HIV positive patient had the external fixator removed due to 
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infection. Analysis of individual pin sites showed that HIV positive patients were more 
likely to be treated with antibiotics than HIV negative patients for pin site sepsis, and 
that the mean pin score was significantly higher in the HIV positive patients. It was 
also noted that the HIV positive patients had the external fixator on for a longer 
period of time, although the criteria for removal have not been discussed. They were 
unable to show any correlation of infection with CD4 count.  
External fixation requires maintenance of the mechanical properties of the bone 
pin interface. Conventional pins are associated with a gradual deterioration of this 
interface over time, and consequent loosening and or infection132. It is possible that 
the results of the study by Norrish et al6 is due to delayed fracture healing placing 
more pressure on the pin/bone interface for longer periods of time and hence the 
higher rates of infection. 
Norrish et al used individual pin sites for statistical analysis, so one patient 
accounted for 6 pin sites, and therefore 6 data entries. If a pin site becomes infected 
or loose, it is likely that the other pin sites will also become infected due to proximity 
and association through the rigid construct. The lack of independence of the data 
points may invalidate the statistical conclusions that patients with HIV are more likely 
to develop more severe pin site infections. 
 
 Bahebeck et al 1.3.3.1
In 2009 Bahebeck published a prospective series of patients who underwent 
implant surgery in the trauma and orthopaedic department in their hospital in 
Cameroon they looked at weather starting early ARV treatment and giving prolonged 
ABx improved outcome. It was a consecutive series, but excluded all patients with 
open fractures, with non-unions, and all patients who were lost to follow up, had a 
CD4 count below 500, or any sign of AIDS. The admitted 1145 patients for implant 
operations over a 36 month period, of whom 500 were excluded. Of those included 
74 had HIV. Their study showed that all patients did well regardless of the 
intervention, with very little difference between the groups, with a 5.4% infection rate 
in the HIV positive patients and a 6.5% in the HIV negative patients. This study adds 
weight to the hypothesis that early HIV does not interfere with wound healing in 
clean procedures. 
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 Summary 1.3.3.2
   
The studies that have included closed fractures have been unable to demonstrate 
any significant difference in the early outcome of asymptomatic HIV positive and HIV 
negative patients. They generally did not look at rates of delayed sepsis or union 
rates. Groups that have limited evidence for being at higher risk of developing wound 
infections in patients with HIV are open fractures, fractures to the tibia and patients 
with opportunistic infections secondary to HIV. 
The studies that included open fractures remain limited. All the trials suggest 
higher rates of infection in the HIV positive patients, but have only provided weak 
evidence that this was not due to chance alone. All have bias or confounding factors 
which may have affected their results, as discussed above. This review of the 
currently available evidence provides no guidance on how these fractures should be 
treated, i.e. conservatively or with internal or external fixation. These trials provide no 
evidence on the rate of delayed sepsis or union rate. 
At present there seems to be insufficient evidence in the literature to guide 
surgeons in the management of these patients. None of the trials on either open or 
closed fractures included patients on HAART.  
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1.3.4 Surgery and HIV 
 
Many other studies have looked at other surgical procedures, trying to identify 
whether HIV is a risk factor for infection. Many of these studies are retrospective 
reviews of medical records. The quality of these trials is variable and there is a huge 
variety in results. They are summarized in a review article by Rose et al126, who 
notes that although the rate of minor complications may be higher in HIV positive 
patients there is not any obvious difference in outcome. They conclude that HIV 
should not affect surgical management unless there is a good quality trial for the 
specific situation. 
Two papers are worthy of individual note as they are prospective studies. 
Dobson133 in 1997 undertook a prospective case control study looking at 
complications following tooth extraction in healthy HIV positive patients in the 
outpatient setting and compared against age-matched community controls. He noted 
a slight increase in minor post-operative complication in the HIV positive group but 
there was insufficient evidence to suggest that this association is real and not just 
due to chance. All complications were treatable as an outpatient. He concluded that, 
if the patient was well enough to present as an outpatient then HIV seropositivity 
should not affect the management of the patient (with regard to tooth extraction). 
Louis et al in 2007 published the largest prospective cohort study to date looking 
at morbidity following caesarean section in HIV positive patients. Caesarean sections 
are heavily studied, because current guidelines suggest that all HIV positive mothers 
should have a caesarean section, to reduce the risk of maternal to child transmission 
of the virus. Although the data was prospectively collected, it was not initially 
collected for this purpose, and only at a later date was analysis for HIV performed. 
The series included 378 HIV positive patients and compared them to 54,281 HIV 
negative patients. Univariate analysis showed that the HIV positive group were more 
likely to be Afro-American, unmarried, have used tobacco and intravenous drugs 
during pregnancy, and have decreased education in comparison to HIV negative 
group. Postoperatively there were increase in endometriosis, maternal sepsis, and 
maternal death seen in the HIV positive group. CD4 counts or the use of HAART 
were not recorded. They concluded that the risks of caesarean section needed to be 
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weighed against the risk of transmission of HIV to the foetus, and that in low risk 
scenarios caesarean section should be avoided.134. 
This large study supplies the best evidence in the literature that HIV significantly 
affects the mechanisms involved in wound healing and is therefore of possible 
relevance to wound healing in open fractures.  
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1.3.5 Pathophysiology of HIV and wound/fracture 
healing 
 
Many theories have been postulated as to the mechanism with which HIV and 
HAART may interact with bone and wound healing.  
A summary of postulated interactions is given below: 
 Host Factors 1.3.5.1
1.3.5.1.1 Immunosuppression 
 
Bacterial infections are known to be more common in HIV positive patients135,136. 
Episodes of bacterial septicaemia are also noted more frequently in association with 
HIV137-139.  S. aureus infections are also more common in patients with HIV139,140. 
 HIV infects CD4 cells, macrophages and dendritic cells. CD4 cells are thought to 
be involved in cell-mediated immunity, whereas macrophages and dendritic cells are 
thought to be involved in the innate immune system8. CD4, CD8 and macrophages 
have all been shown to be present in soft tissue bacterial infection. It is thought that 
the CD4/8 cells are involved in activating the macrophages in the presence of 
bacterial infection13. 
On initiation of HAART CD4 levels tend to rise, whether these cells regain all their 
functionality is not known. It is thought that macrophages remain infected, and high 
levels of virus have been found in macrophages in patients even when on an 
effective HAART regime 141. It is thought that these virally infected cells are likely to 
be functionally impaired8.  
There is also evidence that HIV can affect the functionality of macrophages even 
if not actually infected with virus, this may be due to a disruption in the inter cellular 
signalling cascades from other infected cells142,143. 
Recent data have suggested that in contrast to opportunistic infections, the 
incidence of Gram positive infections may not be reduced by initiation HAART144-146. 
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In conclusion there are many ways that HIV may lead to increased susceptibility 
to bacterial infection, and this susceptibility may or may not be reduced by HAART 
treatment. 
 
1.3.5.1.2 The immune system and wound healing 
 
The immune system has been shown to be important in wound healing 9. 
Macrophages and lymphocytes have been shown to migrate into the surgical 
wound147 
Macrophages have been shown to be important in wound healing. Guinea pigs 
with depleted macrophages have been shown to have impaired wound healing and 
fibroplasia148,  conversely rats that have had injections dermal of macrophages into 
scars have shown an increase in collagen synthesis and wound breaking strength149. 
They are thought to be critical by both their antimicrobial/phagocytosis role, but also 
in the secretion of enzymes (collagenase,elastase), cytokines and growth factors. 
Macrophages released enzymes and growth factors are listed below9. 
 Tumour necrosis factor–α 
 Interleukin-1 
 Interleukin-6 
 Transforming growth factor–α 
 Transforming growth factor–β 
 Platelet-derived growth factor 
 Insulin like growth factor–1 
 
Many of these processes have been shown to be impaired by infection with HIV8. 
No studies were found looking directly on how this may influence wound healing. In 
vitro studies would suggest wound healing without functioning macrophages may 
lead to a wound that is weaker and more prone to infection, however the complexity 
of wound healing means that this conclusion needs to treated cautiously9. 
Lymphocytes as shown in Figure 1-3, migrate into the wound on day 5 and peak 
on day 7. Suppressor T cells (which includes CD4 and CD8 cells) have been shown 
to be important in recruiting cells(macrophages, endothelial cells and fibroblasts) and 
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also act in a late counter regulatory role, perhaps being responsible for the orderly 
completion of wound healing 150 
Isolated depletion of CD4 T cells has been shown to lead to an decrease in 
wound strength, whereas a depletion of CD8 cells leads to an increase in wound 
strength151. It is hypothesized that these T lymphocytes are involved in the regulation 
of wound healing. 
The role of the immune system in wound healing remains poorly understood. 
Many of the cell lines involved in wound healing are infected in HIV. These cells are 
involved in recruitment, phagocytosis, and the regulation of wound healing. It is 
therefore likely that HIV affects wound healing at some level, but further studies are 
needed to identify these effects. 
1.3.5.1.3 Osteoimmunology 
 
The immune system has been shown to be linked to responses wound and  
fracture healing. Macrophages, lymphocytes and dendritic cells have all been found 
in early callus formation152. 
Cell mediated immunity is also thought to affect fracture healing. T cells have 
been implicated in this process. In one study the thymus was removed  in mice, this 
led to an inhibition of natural killer cells, and T cells153. The result was a significant 
delay in fracture healing compared to controls. The authors concluded that T cell 
immunity was integral in the repair and regeneration of bone tissue. More recently 
Colburn et al 12 have looked at the role of a small subset of T lymphocytes,  γ/δ  and 
their role in fracture healing. These subsets of T lymphocytes are able to recognize 
products of stressed cells without the need for antigen presenting cells, and are 
therefore thought to be part of the innate immune system.  This study looked at 
fracture healing in  γ/δ T lymphocyte deficient animals and controls. It showed the 
localization of γ/δ T lymphocytes to the fracture site in controls, and suggested that 
their presence is detrimental to fracture healing and fracture strength. The exact 
mechanism for this process is not understood, but the authors speculated that it may 
be due to the up-regulation of the α/β T lymphocytes, in the γ/δ T lymphocytes 
deficient animals. The α/β T lymphocytes are thought to be beneficial to bone 
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healing. CD4 cells are  a subtype of α/β T lymphocytes and how HIV infection affects 
these processes has not been studied. 
A recent study by Toben et al14, showed that mice deficient in both B and T 
lymphocyte, had enhanced fracture repair, with a stronger and more rapidly 
occurring healing. A reduction in inflammatory ctyokines and an up regulation of anti 
inflammatory interleukins was observed in callous compared to that of the controls.  
Gaston et al has shown that in long bone fractures in mice, macrophages and T 
cells are recruited into the fracture site. In the same study nude mice, depleted in T 
and B cells, had enhanced fracture repair, with a stronger and more rapidly occurring 
bone healing154. Individual cellular lineages responsible have not yet been identified. 
The exact role of the macrophage in fracture healing has been poorly studied. It 
has been observed in the callus, and many of the inflammatory mediators found in 
the callus are known to be released by macrophages155. It is likely that its role is 
similar to that in wound healing, one of recruitment of other cells, stimulation of cells 
and phagocytosis of bacteria or foreign bodies. 
A literature search, revealed no experimental studies into HIV effects in 
osteoimmunology in either human or animal studies.  
Major trauma is known to lead to a suppression of systemic cell mediated 
immunity156,157; how this occurs is poorly understood. Many theories have been 
postulated, these are summarised by Ayala et al in a review article156. They conclude 
that changes in the antigen presenting cells at the fracture site, lead to a suppression 
of the cell mediated immunity and macrophages play a critical role in this process. 
How an HIV infected individual may react to major trauma has not been studied. It is 
possible that damage to the macrophages in HIV positive patients may alter their 
response to major trauma.   
1.3.5.1.4 Hypoalbuminaemia 
 
HIV positive patients are known to have increased rates of hypoalbuminaemia 158 
In the catabolic phase post trauma, and post-surgery, albumin levels are likely to 
drop further159. Low albumin has been shown to be deleterious to wound healing and 
fracture healing74,160. 
1.3.5.1.5 Vascular Disease 
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HIV positive patients are at high risk of developing vascular disease both 
cardiac161 and peripheral162,163 despite lower incidence of traditional risk factors. 
Periard et al concluded that there is an epidemic of peripheral vascular disease in 
HIV positive patients which is presenting approximately 20 years earlier than would 
be expected in the general population164.  
A variety of different mechanisms for this have been proposed. For cardiac 
disease the hypothesis is that HIV affects visceral fat distribution165 leading to 
Metabolic Syndrome. This syndrome occurs in the normal population and is 
associated with central obesity, diabetes and hypertension. In HIV patients it 
appears to be more severe, with higher TG levels and lower HDL, despite a lower 
BMI when compared to similar patients with Metabolic Syndrome without HIV166,167. 
After starting treatment with HAART, hypercholesterolemia and hypertriglycaemia is 
often seen. However HDL levels still do not return to normal168 . The 
hypercholestrolaemia is thought to be due to HIV infected macrophages being 
unable to discharge the cholesterol they have mopped up. This makes them 
redundant for cholesterol transport169.  HIV and HAART (Protease Inhibitors 
particularly) are also thought to increase the expression of CD36 markers on 
macrophages. These markers are critical for the formation of foam cells an essential 
precursor to atherosclerotic lesions161. 
Other mechanisms: 
HIV patients appear to be in a state of sustained acute phase response, as a 
result of the viral infection: this is shown by a relatively high CRP seen in these 
patients170. Sustained high CRP has been shown to correlate well with cardiac 
vascular disease171 
TAT protein is released from HIV infected cells, this interacts with endothelium, 
and leads through a variety of pathways to endothelial dysfunction172,173 
Dying CD4 cells, lead to increased production of shed membrane particles, these 
lead to a reduction in nitric oxide, and prostacyclins, leading to vasoconstriction and 
endothelial dysfunction174 
Since vascular supply to both the bone and the wound are critical for healing, 
damage to the endothelium and the vessels supplying the fracture site/wound, are 
likely to lead to increased wound infections and decreased union rates. 
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1.3.5.1.6 Osteoporosis 
 
Several cross sectional studies have shown high rates of osteoporosis and 
osteopaenia in HIV patients compared to normal controls115,175,176. They have 
hypothesiszed that this might be due to modulation to the TNF alpa superfamily177 
HAART treatment has also been implicated in osteoporosis, although this group of 
patients also tend to be the ones who have had the longest exposure to HIV118. The 
mechanism by which HIV causes osteopaenia  is not known, however a variety of 
biochemical markers involved in bone metabolism have been shown to be altered in 
HIV infection. 
Osteocalcin – seen in lower levels in HIV positive patients178-180 -,  increasing 
levels seem to correlate with increased rates of bone formation in fracture healing181 
TNF alpha – seen in high levels in HIV patients – Can stimulate both osteoblasts 
and osteoclasts. Its exact role has not been elucidated182. 
Osteoporosis can lead to difficulties in obtaining stable fixation with screws 
because of poor bone quality, this may then lead to premature failure of the bone 
fixation. 
 
1.3.5.1.7 Prophylactic antibiotics in HIV positive patients 
 
Studies have suggested that bacterial carriage may differ in HIV positive and 
negative populations. These studies have suggested that HIV positive patients may 
have higher rates of S. aureus on nasal swabs, and also higher rates of resistance, 
particularly MRSA183-187. Rates of S. aureus carriage and resistance patterns vary 
significantly between different populations and different institutions. Studies done on 
healthy volunteers with and without HIV failed to show any variation in colonization 
rates188. Trauma patients (with open fractures) are generally young and otherwise 
healthy, however on admission, all will have i.v. cannulas inserted, and be started on 
prophylactic antibiotics. They also are admitted to hospital for anywhere between 2-
60 days. These factors all predispose them to becoming carriers of nosocomial 
bacteria.   
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In HIV positive patients, the use of prophylactic antibiotics against opportunistic 
infections such as Co-trimoxazole has been implicated in the high levels of resistant 
bacteria found on nasal swabs183,184,189. In South Africa all patients with HIV and a 
CD4 count below 500 cells/µL, as well as infants exposed to HIV during child birth 
are advised to take Co-trimoxazole.  
Whether these factors affect the antibiotics that should be used for prophylaxis in 
open fractures has not been studied, but may be relevant factor in the development 
of wound sepsis. 
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 Environmental Factors 1.3.5.2
1.3.5.2.1 Multiple Hospital attendance 
 
Patients with HIV are at higher risk of developing many pathologies and therefore 
are likely to spend a greater proportion of time in hospital than the general 
population190. Once diagnosed with HIV, even patients who are well are likely to 
spend increased time in hospital, as they are screened for opportunistic infections, 
base-line bloods are taken, and results given. This period of time spent in hospital 
may alter the patient’s bacterial flora, so increasing the chances of colonization by 
resistant species such as MRSA139. 
1.3.5.2.2 Decreased social group/education 
 
The social demographics of the HIV positive population are very dependent on 
the predominant local route of transmission. The demographics of intra-venous-drug 
(IVD) users, homosexual and heterosexual transmission groups will vary 
dramatically. Many studies have shown a lower education level in their HIV positive 
cohort134. This may be a relevant confounder when looking at outcomes. High risk 
behaviour such IVDU, and smoking, may be seen in higher rates in certain cohorts of 
HIV positive patients134. Smoking has been shown to be detrimental to fracture 
healing78, and IVD use may lead to increased rates of S. aureus septicaemia 
compared with the general population.  This may lead to delayed sepsis of metal 
work191. 
1.3.6 Implant infections in HIV 
 Acute Infection – within 6 weeks of operation 1.3.6.1
 
Acute implant sepsis occurs in the first 6 weeks postoperatively. Bacteria invade 
through the open wound, or surgical site, and in the presence of favourable 
conditions (necrotic bone, mobile fracture or damaged/contaminated tissue) will 
colonize the implant, create a biofilm, and may lead to chronic sepsis; this process is 
described in section 1.3.2.  
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It has been postulated that in cases of contaminated fractures, bacteria may lie 
dormant, adherent to the implants for many years. If the immune system falters the 
bacteria multiply and sepsis follows192. This may be difficult to differentiate from late 
infection. 
1.3.7 Late implant infections in HIV 
 
Late infection is most commonly due haematogenous spread, often from a S. 
aureus bacteraemia. In this process bacteria enter the blood stream from a site 
unrelated to the implant. S. aureus can bind to metallic implants and lodge at the 
implant site. Late infection can occasionally be due to reactivation of bacteria that 
initially contaminated the wound at the time of the initial injury193.   
Murdoch et194 al showed that following a S. aureus bacteraemia, 34% of joint 
prostheses, but only 7% of orthopaedic implants became infected.  In a retrospective 
study looking at joint replacements in HIV infected haemophiliacs, Hicks et al195 
noted high rates of delayed sepsis; these being 18.7% in patients undergoing 
primary procedures, and 36.3% of patients undergoing revisions, with a mean delay 
between surgery and sepsis of 47 months. The incidence of S. aureus bacteraemia 
in the HIV positive population appears to be more common 137-139.  Burkley et al191, in 
a study at John Hopkins Hospital (USA),  showed a 12% incidence of MRSA 
bacteraemia  per patient year in HIV positive patients. Risk factors for bacteraemia 
were found to be: intravenous drug use, low CD4 and end stage renal disease. 
Harrison et al have published a study looking at delayed sepsis in a cohort of 36 
HIV positive patients treated with internal fixation treated for closed fractures, looking 
at rates of delayed sepsis at 1 year. They had no cases of metal work removal due 
to infection at 1 year. 
 In summary there is significant theoretical evidence supporting the removal of 
implants in HIV positive patients once fracture healing has occurred; however there 
are few clinical trials addressing this issue. In resource-limited settings such as sub 
Saharan Africa, the resources are often not available for routine removal of implants. 
In the development of guidelines for the acute management of these patients in the 
above setting, it is important to know about the long-term morbidity of internal 
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fixation. Hence the need for long term follow up studies of internally fixed fractures in 
HIV positive patients. 
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1.4 Conclusions 
The treatment of open fractures with internal fixation, in certain situations is now 
considered the optimal method of fixation for obtaining union54. The most serious 
complications associated with this type of management are infection and non-union. 
There are many factors that influence the development of infection in the presence of 
metal work. Optimizing these factors appears to have led to a dramatic decrease in 
the rates of infections. However once infection has occurred, it remains difficult to 
treat and often requires removal of the metal work and surgical debridement. 
The pathophysiology of HIV is complex and affects a huge variety of pathways 
many of which are related to fracture management and healing. There are few 
clinical studies looking at outcomes in open fractures in relation to HIV. These 
studies involved small numbers and most did not attain statistical significance 
however they all suggested higher rates of infection than in controls. There are no 
experimental studies on the effect of HIV on fracture healing. However the clinical 
trials combined with a strong theoretical basis of how HIV and HAART may influence 
fracture management necessitates a larger prospective study looking at the clinical 
outcomes. 
Aspects felt to be important which have not been adequately investigated are: 
Whether HIV is a significant risk factor in the development of wound infections or 
non union in open fractures? 
Whether the rate of wound infections/complications correlates with the CD4 count 
in HIV positive patients? 
Whether external fixation a viable alternative to the treatment of these fractures in 
this group? 
Whether the initiation of HAART affects rates of infection or non union? 
What is the incidence of delayed sepsis in HIV positive patients with metal work in 
situ, and whether we should routinely be removing metal work in these patients? 
 
The Aims of this project are based on the lack of evidence, highlighted above, 
and the clinical and material resources that were available to us. 
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1.5 Aims of the study 
To investigate the following null hypotheses:  
1. That there is no association between HIV (or advanced HIV) and 
wound infection in open fractures treated with surgical stabilization. 
2. That there is no association between HIV (or advanced HIV) and 
non union in open fractures treated with surgical stabilization. 
3. That there is no association between HIV (or advanced HIV) and 
wound infection in open fractures treated with internal stabilization. 
4. That there is no association between HIV (or advanced HIV) and 
non union in open fractures treated with internal stabilization. 
5. That there is no association between HIV (or advanced HIV) and pin 
site sepsis in open fractures treated with external fixation. 
6. That there is no association between HIV (or advanced HIV) and 
non union in open fractures treated with external fixation. 
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Chapter 2 
Material and Methods 
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2 Material and Methods 
2.1 Location 
 
Because of the high incidence of trauma in an area where HIV is prevalent, 
providing a rich source of clinical material, the study was carried out on patients 
admitted to the accident and orthopaedic departments of Ngweelzane Hospital, 
Empangeni, Kwazulu Natal, South Africa.  
Kwazulu Natal is a province in the North East corner of South Africa. Its capital is 
Durban, it goes north to Mozambique and Swaziland border, and in the west it 
borders Lesotho. There is considerable health migration from these bordering 
countries. This leads to a heavy burden being placed on the government funded 
hospitals in the province.  Figure 2-1 shows the location of Ngwelezane Hospital and 
the area from which it receives referrals.  
 
 
Figure 2-1 Illustrating the referral area of the study hospital 
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The hospital takes referrals from 13 peripheral hospitals. It supplies services for 
orthopaedic and general surgery, internal medicine, paediatrics, casualty, intensive 
care, ophthalmology, infectious disease, TB and HIV medicine. It has an associated 
obstetrics and gynaecology hospital nearby. Radiology is available 24 hours a day, 
with a multi-slice CT scanner, and an MRI scanner. The Orthopaedic Department is 
staffed by 1 permanent consultant, 1 part time consultant, 5 medical 
officers/registrars, and 5 interns/house officers. 
The hospital provides referral services to an area 36396 sq. km, and a population 
of 2.3 million, equivalent to that of approximately half the size, and half the 
population of Scotland. It is a largely rural area, with only 10% of the population 
currently employed. The average income per capita per annum is 2565 ZAR ($256). 
The quality of the roads is also poor with three of the peripheral hospitals 
approximately four hours’ drive away. The hospital has access to helicopter and 
fixed-wing aircraft for emergency transfers from rural hospitals. The helicopter is 
unable to fly at night. These services are utilized in life and limb threatening 
scenarios. At night however all forms of transport are dangerous, and if possible 
transfer will wait for daylight hours.   
Mtubatuba, a town approximately 60km north of the hospital, has been shown to 
have one of the highest rates of HIV in pregnant women in the world, namely 38%. 
 It is an area of heavy trauma workload, which comes from three sources: 
Motor vehicle accidents (MVA)/Pedestrian vehicle accidents (PVA). The roads 
are of poor quality: the informal buses/pickups are overcrowded and frequently 
crash. Rural roads often have animals on them, making driving at night dangerous, 
and there is a high incidence of drink-driving. These factors mean that MVAs and 
PVAs, with severe trauma, and often open fractures, are commensurately frequent.  
Gun-shot injuries, often alcohol-related, predominantly from low energy hand 
guns and occasional shot guns 
Domestic violence/ village justice – often involves multiple chops by a bush knife 
to the forearm and hands. The blades and the wounds are normally clean but not 
sterile.  
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2.2 Trial design 
Given the evidence discussed in the introduction which has suggested that HIV 
infection might lead to higher wound infection through a variety of effects, both direct 
and indirect. It is postulated that as HIV advances and CD4 count falls the effect on 
risk of wound infection might rise. The method of fixation is dependent on a variety of 
factors, as discussed in section 2.7.7, including HIV status. It is not known if the 
method of fixation leads to a difference in wound infection rates, and whether HIV is 
a more important risk factor given certain types of fixation. These relationships are 
summarised in Figure 2-2. 
 
 
The scope of this thesis was not to make a direct comparison of internal and 
externally fixation for open fractures, but to make an assessment of both of their 
suitability to treat open fractures in patients with HIV, whilst also assessing the effect 
HIV has on fracture and wound healing .  
Figure 2-2 Showing the possible routes of association between HIV and wound infection 
HIV Wound 
infection 
Hypo albuminaemia 
Anaemia 
MRSA carrier 
Vascular disease 
Osteoporosis 
 
Grade of wound,  
Energy of injury 
Delay to surgery, 
Smoking 
Confounders 
Causal Pathway 
CD4 count 
Potentially affected by 
HIV status 
Method of fixation 
Effect Multiplier 
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In assessing the effect of HIV infection on non union and pin site sepsis a similar 
diagram can be constructed, the only difference being the addition of wound infection 
as a potential risk factor for non union. These relationships are summarised Figure 
2-3 and Figure 2-4 
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HIV Pin site sepsis 
Hypo albuminaemia 
Anaemia 
MRSA carrier 
Vascular disease 
Osteoporosis 
Delayed/non union 
 
Grade of wound,  
Energy of injury, 
Smoking 
Confounders 
 CD4 count 
Effect Multiplier 
Figure 2-4 Showing possible mechanisms of association between HIV and Pin site sepsis 
Causal Pathway 
HIV Non Union 
Hypo albuminaemia 
Anaemia 
MRSA carrier 
Vascular disease 
Osteoporosis 
Wound Infection 
 
Grade of wound,  
Energy ofinjury, 
Smoking 
Confounders 
Causal Pathway 
CD4 count 
Effect Multiplier 
Figure 2-3 Showing possible mechanisms of association between HIV and non union 
Potentially affected by 
HIV status 
Method of fixation 
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2.3 Patient Cohorts 
 
In order to address the different aims of the study, 3 distinct cohorts of patients 
were chosen as shown in Figure 2-5 . The data from the different cohorts is analysed 
and discussed independently. These cohorts all have distinct inclusion and exclusion 
criteria: 
 
  
 
Figure 2-5 Illustrating the 3 cohorts used in data analysis 
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2.4 Cohort 1: Open fractures treated by surgical fixation 
 
This cohort will be studied using a prospective-epidemiological-observational 
study to examine the rates of wound infections and fracture union  
2.4.1 Inclusion Criteria 
 
All adults (over 16, so able to consent for an HIV test) admitted to Ngwelezane 
hospital who underwent internal or external fixation for open fractures (including 
significant  abrasions over fracture site) between the between the 27th May 2008 an 
d the 3rd March 2009 . 
Harrison et al3, looked at patients who had broken skin at the fracture or in the 
vicinity of the operative site, and placed these patients in infection risk category one. 
It was using these selection criteria that the authors showed a high rate of infection. 
It was therefore felt appropriate to include such patients, with significant abrasions, 
within the open-fracture classification. 
2.4.2 Exclusion Criteria 
Exclusion criteria were designed to try and reduce the heterogenirty of the 
patients, and to prevent the effect of a loss to follow up bias, by excluding patients 
who we would have trouble getting to come back to clinic.  
Intensive care treatment 
Mental illness/Dementia 
Patients from outside the hospital catchment area requesting ongoing treatment 
at their local hospital 
Patients who were unable to provide contact information, such as a phone 
number, in order to chase if missed appointment. 
Patients who were discharged to a prison other than the local Empangeni prison, 
due to difficulty in getting follow-up from these institutions 
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2.5 Cohort 2: Open fractures fixed by internal fixation 
 
This cohort will be studied using a prospective-epidemiological-observational 
study to examine the rates of wound sepsis and union rates. It will attempt to identify 
risk factors, particularly with relation to HIV, for the development of wound infections 
or non-unions.  
2.5.1 Inclusion Criteria 
 
All adults (over 16) admitted to Ngwelezane hospital who underwent internal 
fixation for open fractures between the 27th May 2008 and the 3rd  March 2009 .  
2.5.2 Exclusion Criteria 
 
It was felt inappropriate to include the following categories of patients in the 
series.   
Intensive care treatment 
Mental illness/Dementia 
Patients from outside the hospital catchment area requesting ongoing treatment 
at their local hospital 
Fixation using K wires, with the intention for removal at approximately 6 weeks 
(as not regarded as internal fixation) 
Patients unable to provide contact information, such as a phone number in order 
to chase if non-attendees at follow-up 
Patients who were discharged to a prison other than the local Empangeni prison, 
due to difficulty in getting follow-up from these institutions 
2.6 Cohort 3: Open fractures treated by external fixation 
 
This cohort will be studied using a prospective-epidemiological-observational 
study to examine the rates wound and pinsite infections and fracture union.  
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2.6.1 Inclusion Criteria 
 
All adults (over 16) admitted to Ngwelezane hospital who underwent external 
fixation for open fractures (including abrasions) between the between the 27th May 
2008 and the 3rd March 2009 . 
2.6.2 Exclusion Criteria 
 
Intensive care treatment 
Mental illness/Dementia 
Patients from outside the hospital catchment area requesting ongoing treatment 
at their local hospital 
Patients unable to provide contact information, such as a phone number in order 
to chase if non-attendees at follow up. 
Patients who were discharged to a prison other than the local Empangeni prison, 
due to difficulty in getting follow-up from these institutions 
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2.7 Preparatory work 
2.7.1 Power studies 
 Wound infection in internally and externally fixed 2.7.1.1
fractures 
 
The study reported by Harrison et al from Malawi3, was used as a pilot.  
In their small cohort of patients with open or “high risk for infection” fractures 
treated by internal fixation (n=39) there was a 4.2 times increase in the rate of wound 
infection in the HIV positive group (n=12) of patients. 
 However, a power calculation, calculated using Epi Info (ver 3.4.3, see appendix) 
using 95% confidence, 80% power, and a ratio of uninfected to infected patients of 
3:1, shows that the number required to permit statistically valid conclusions were: 21 
HIV positive patients and 63 HIV negative patients.  
Retrospective data from a review of the operating lists, suggested that at 
Ngwelezane Hospital on average 5 open fractures a week were internally fixed. With 
an approximate background rate of HIV of 30%, it was estimated over the nine 
month period available to complete such a study 180 open fractures would be 
operated on, 54 of whom would be HIV positive. This would enable statistically valid 
conclusions to be drawn, for both the combined cohort and the internal fixation 
cohort. 
 Non Union in internal and externally fixed 2.7.1.2
fractures 
 
The paper published by Jellis4, is the only data available regarding non-union 
rates in internally fixed HIV positive patients. He quotes a non union rate of 35 % in 
open fractures treated with internal fixation. The demographics of his population are 
not commented on. Reports of  non union rates in HIV negative patients vary196 but a 
rate of 5% in a varied set of injuries, which are predominately grade 1 and 2 was 
thought to be reasonable by the authors. 
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A power calculation, calculated using Epi Info (ver 3.4.3) using 95% confidence, 
80% power, and a ratio of uninfected to infected patients of 3:1, shows that the 
number required to permit statistically valid conclusions were: 16 HIV positive 
patients and 48 HIV negative patients. 
The retrospective data discussed in 2.7.1.1 suggests that it would be possible to 
enrol this number of patients in the time period available to us. This would enable 
statistically valid conclusions to be drawn, for both the combined cohort and the 
internal fixation cohort. 
 Pin-site sepsis in externally fixed fractures  2.7.1.3
 
The study by Norrish et al6 was used as a pilot. In their cohort of patients treated 
by external fixation for open fractures (n= 50), they showed rates of pin-site sepsis 
(Checketts grade 2 or greater) of 44% in the HIV positive group (n=15) and 11% in 
the HIV negative group (n=35).  
In a power calculation using Epi Info (ver 3.4.3) with 95% confidence, 80% power, 
and a ratio of uninfected to infected patients of 3:1, the minimum numbers required 
would seem to be: 17 HIV positive 40 HIV negative patients. Retrospective data on 
the number of patients treated to union with external fixators were not available. It 
was felt that the recruitment of 17 HIV positive, and 40 HIV negative patients should 
be possible within 9 months. 
 Non union in externally fixed fractures  2.7.1.4
 
Rates of non union in externally fixed fractures are likely to be higher than those 
treated with internal fixation because the underlying injury is likely to be more severe. 
Using evidence from the literature, and experience from our unit, the expected non 
union rate in the HIV negative populations was estimated at 6%. Harrison et al 
published work on the non-union rates of severe open tibia fractures treated initlly 
with external fixation, but converted to cast once the soft tissue injury allowed, in the 
HIV positive patients he had a non-union rate of 42% 
In a power calculation using Epi Info (ver. 3.4.3) with 95% confidence, 80% 
power, and a ratio of uninfected to infected patients of 3:1, the minimum numbers 
required would be:15 HIV positive 45 HIV negative patients. Retrospective data on 
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the number of patients treated to union with external fixators were not available. It 
was felt that the recruitment of 15 HIV positive, and 45 HIV negative patients should 
be possible within 9 months. 
2.7.2 Ethics 
 
The approval of the Consultant Staff for this study was generously given, and the 
protocol of management developed and approved. 
The Protocol was submitted to the Regional Health Authority, including the 
methods of consent for both HIV testing and entry into the trial. A requirement of the 
ethics panel was that the management of the patients was not altered from the 
departmental policy at the time. This policy is summarised in section 2.7.7.  
Regional and National ethical approval was given. 
2.7.3 Consent 
A verbal summary of the trial and the implications of entering it was given to all 
patients who met the entry criteria, this was given in either Zulu or English. This was 
reinforced with a patient information leaflet, again in the two languages. A consent 
form, translated in both English and Zulu was also given, if patients were happy to 
enter the trial a signature or thumb print was placed on the form. 
2.7.4 Trial Time Line 
 
Preliminary work for the study was started in May 2008, and work was completed 
by May 2009. Exact timings are shown in Figure 2-6 
 
 
 
  
 
Figure 2-6. Showing time line for research project 
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2.7.5 Data collection 
 
A proforma was designed to aid data collection from the patients and to ascertain 
that all relevant risk factors for wound infections, as discussed in the literature 
review, were recorded. The proforma employed is shown in Figure 2-7 : 
 
 
 
Figure 2-7 
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2.7.6 Data Management 
 
Data were initially collected on paper proformas. These were stored in the lead 
consultant’s secure office. The data were entered weekly into an electronic database 
created by Epi Info (ver. 3.4.3). This database was password protected. Patient 
consent forms for entry into the trial, were collected during primary admission, these 
were kept by the lead investigator. Consent for HIV testing was made in the patient 
notes, as per hospital protocol. 
2.7.7 Patient Management   
 
The system of patient management at Ngwelezane Hospital was based on 
national and local guidelines. The care pathway from admission to discharge is 
summarised in figure Figure 2-8 and Figure 2-8 
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 Care pathway from admission till theatre 2.7.7.1
 
  
Included/Excluded 
from study. Initial 
data acquisition  
Patient injured 
open fracture 
Admitted to 
Ngwelezane, 
Casualty 
Admitted to 
peripheral 
Hospital 
Triage by 
nurses –  
Assessed by a 
Doctor in Resus 
or casualty 
Antibiotics as per 
protocol, Tetanus 
toxoid  
Clexane started.  
Referred to and 
seen by senior 
orthopaedic 
doctor 
Emergency 
Theatre 
Ward 
Decision for 
Debridement and 
possibly definitive 
fixation made 
Intensive 
Care 
Excluded from 
trial 
Basic 
emergency 
care.  
Elective 
Theatre 
 
Figure 2-8. Flow chart showing initial patient management 
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 Post operative management and follow up 2.7.7.2
 
  
Patients with metal work 
are rung every 6/12 to 
check no signs of sepsis 
Surgical details 
entered into 
database 
Assessed 
for 
discharge 
Seen at 6 
weeks 
Seen at 12 
weeks 
Pt reassessed 
(wound scored) 
every 2 days, by JJA 
or consultant familiar 
with trial protocol  
Orthopaedic 
list 3 days a 
week.  
Dedicated clinic, run by 
JJA. Details entered 
straight into database 
6 month fu 
over the 
telephone 
Radiographs, Wounds 
assessment, reoffered 
HIV test 
Non attendees 
contacted by 
cell phone 
Elective 
Theatre 
 
Ward 
 
Exclude
d from 
Trial 
Further 
Exclusion 
criteria 
Seen in FU 
clinic at 2 
weeks 
Non attendees 
contacted by 
cell phone 
Non attendees 
contacted by 
cell phone 
Radiographs retrospectively 
reviewed by a blinded surgeon 
Figure 2-9. Flow chart showing patient management once admitted to ward 
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2.8 Treatment protocols 
The management of open fractures is based on the experience of the lead 
consultant (PR), the evidence available in the literature, and the resources available. 
In order to standardize care for the trial, these management principles were 
summarized in the protocols in sections 2.8.2 to 2.8.5.  The lead clinician(PR) assed 
and graded all the wounds, post debridement and this was then recorded on the 
patients proforma when they were assessed postoperatively by the lead researcher 
JA. 
2.8.1 Method of Fixation 
The method of fixation was standardized. All intramedullary nails of the tibia and 
femur where Trigen nail, using the maximum diameter possible for the bone. 
Intramedullary devices in the forearm where rush rods, and the humerus were locked 
Synthes nails. All locking plates were fixed angle synthes plates. External fixators 
were generally monolateral Ortho-fix Fixators, however if the fracture type required, 
circular fixators were used. 
 
2.8.2 Antibiotic Protocol 
This followed regional guidelines, and is based on the Gustilo Anderson 
classification: 
 
 
Abrasions 
Grade 1 
Grade 2 
Grade 3 
Cloxacillin 1g qds started on admission, 
Gentamycin 240mg for injuries below mid-shaft 
tibia. Continued for 24 hours post final surgery 
As for grade 1 
As for grade 1, except Gentamycin included in all 
grade 3 fractures 
Receive preoperative antibiotics of Cloxacillin 1g. 
Gentamycin 240mg is added for injuries below the 
mid-shaft of the tibia.  
Figure 2-10.  Flow chart showing use of prophylactic antibiotics 
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2.8.3 Tibia Fracture Protocol 
 
 
Figure 2-11. Flow chart showing the management protocols for open tibia fractures 
 Monitoring of patients whose treatment was 2.8.3.1
affected by HIV status 
The surgeon was not blinded to the HIV status. In our setting with limited 
resources this was not feasible, and it was a condition of the ethics approval that 
management was not altered from that previously in place at the hospital. It is 
therefore possible that the choice of fixation was influenced by HIV status.  Any case 
where HIV was thought to have influenced management was noted at the time, any 
patient who according to the protocol in Figure 2-11   could have had their 
management affected had their notes reviewed.   
Open Tibia 
# 
Minimally 
displaced  
Minimally displaced, fractures, 
and the soft tissue allows 
treatment in POP for 12-16 
weeks 
Significantly 
displaced grade 
1,2 with 
contamination HIV  +ve  
or wound not clean 48 
post debridement 
HIV –ve and  
wound clean at 48 
hours 
Continu
e with 
external 
fixation 
Delayed 
IM 
nailing  Debride 
and 
initial 
Ex-Fix 
 
Significantly 
displaced grade 
1,2 with no 
contamination 
Intramedullary (IM) fixation, 
either immediate or delayed. 
Grade 3  
Debridement and Ex-Fix, wound 
inspection at 48 hours, then 
consider SSG or flap. If soft 
tissue management difficult, 
consider conversion to locking 
plate 
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2.8.4 Management of wound infections 
 
 
 
Wound infection 
Fracture 
not united 
Fracture 
united 
Swab taken, Started on Abx – 
Cloxicillin 500mg qds, and 
Ciprofloxacin 500mg bd. 
Regular dressing changes. 
Review 1 week 
Infection fails to 
resolve 
Infection resolves 
Remove metal work, and 
debride as appropriate. 
Continue on appropriate 
antibiotics till infection 
settles 
Careful 
Follow up 
Attempt infection 
suppression with 
antibiotics. If Non union 
develops, consider metal 
work removal, and 
appropriate non union 
treatment  
Figure 2-12. Flow chart showing the management of suspected wound infection 
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2.8.5 Management of patients with suspected pin site 
infections 
 
 
 
 
  
Attempt infection 
suppression. If non union 
develops or pin loosening on 
radiographs then, remove 
exfix and consider other form 
of stabilization 
Suspected pin 
site infection 
Infection 
not settling 
Infection 
settles 
Wound swab taken, Patient started 
on Abx –Cloxicillin 500mg qds. Pt 
sent for radiographs 
No loosening on 
radiographs 
Loosening on 
radiographs 
Close FU till union 
and exifx removal 
Remove ex-fix 
and consider 
other form of 
fixation 
Lesson on 
Pin care, 
Review 1 
week 
Figure 2-13. Flow chart showing the management of suspected pin site infection. 
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2.9 General material and methods for all aspects of trial 
2.9.1 HIV testing 
 
Patients were all counselled prior to testing, and written consent obtained and 
documented in the notes. Patients, who declined testing, were reoffered testing at 
follow up. All patients were followed whether or not  they agreed to testing. 
HIV tests available were: 
Abbott Diagnostic OraQuick Rapid HIV-1/2 Diagnostic Test. This has been shown 
to be a rapid and reliable test in the sub-Saharan African setting197. This test was 
utilized by the walk-in HIV testing centres on site. The sample was taken from a 
finger prick and the test done in front of the patient. For this trial, these tests were 
utilized when patients agreed to have a test when coming to follow up. Patients 
would have the Oraquick test, if positive it would be confirmed with an ELISA. 
ELISA: These tests were done using the Abbots Diagnostic IMX platform and the 
HIV-1/HIV-2 3 plus reagents. This has been shown to be one of the most sensitive 
immuno assay systems available198. This test was utilized for all ward patients, and 
for confirmatory tests, of patients tested with the Oraquick  test. 
2.9.2 CD4 Testing 
CD4 tests were all done using flow cytometry, tests were all taken at least 3 days 
post trauma and on average 1 month post trauma. Many patients would not consent 
to HIV testing at the time of injury but at subsequent follow up, it made it difficult to 
standardize timing of the test. Patients who were on ARV’s were all having regular 
CD4 counts, therefore if one was available within 3 months of injury this was taken, if 
not a repeat sample was taken. Due to the current lack of evidence on whether 
HAART adversely affects wound or fracture healing we have taken the most recent 
CD4 even if previous CD4 counts prior to starting treatment had been lower. 
2.9.3 Microbiology technique 
 
Wound swabs were taken in theatre if more than 24 hours had elapsed since the 
injury. Previous studies suggest that swabs taken in theatre at the time of initial 
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debridement, are of little clinical use, as swabs grow contaminants that rarely lead to 
wound infection, if the time since injury is less than 24 hours86-89.  
Wound swabs were taken of wounds or pin sites on the ward or in clinic at any 
time if there were significant exudate or erythema  
 
Microbiology swabs were collected using sterile dacron swabs placed in an 
AMIES gel-based medium, manufactured by EUROTUBO. Swabs were subjected to 
a Gram stain and culture within 24 hours of being taken. Staphylococci and 
Streptococci were placed on blood agar, and Gram negative organisms were placed 
on McConkeys Agar. Swabs were read at 3 days and sensitivities obtained using a 
VITEK 2 automated system. Antibiotic sensitivities tested for were: 
Gram positive organisms: 
Penicillin, Erythromycin, Oxacillin, Clindamycin, Vancomycin, Cefalothin, 
Gentamycin 
Gram negative organisms: 
Ampicillin, Amikacin, Cefuroxime, Cefotaxime, Gentamycin, Ciprofloxacin 
2.9.4 Time from injury to administration to antibiotics 
 
Many of the patients recruited into the trial were referred from peripheral 
hospitals, poor documentation regarding time of administration of antibiotics made 
the accurate assessment of delay to antibiotics impossible to assess. 
2.9.5 Albumin 
 
Blood for serum albumin levels was taken within the first 48 hours of admission, 
and was assayed as part of the routine liver function tests. Patients with an albumin 
<35g/l 
2.9.6 Methods of Classification used 
 Open fracture 2.9.6.1
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We used the modified Gustilo Anderson classification25 for open fractures. Gun 
shot wounds as discussed in section 1.2.1 were assumed to be low energy, and the 
grading was therefore based on the wound characteristics 
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 Classification of union 2.9.6.2
Two separate classifications were utilised, based on recent literature review on 
the subject by Corrales et al 199: one on radiological grounds and the other on clinical 
grounds, these systems were  
Clinical fracture union was defined as being ability to fully weight bear without 
pain at the fracture site, or in non–weight-bearing limbs, as being non tender over 
the fracture site. This was utilized especially in patients who had external fixators 
removed, so had no internal fixation. 
Radiological union was defined as the presence of bridging callus on at least two 
cortices. 
Location specific definitions are taken as the commonly used definitions in the 
literature as shown in Table 2.1 199. 
Table 2-1 Showing the criteria required to make the assessment of union, taken from 
commonly used definitions in the literature
199
 
  
Femur Tibia Humerus Forearm 
Proximal fracture  
 Radiographic 
assessment 
Bridging of 
fracture site 
Obliteration of 
fracture line 
Obliteration of fracture line or bridging 
of fracture site 
— 
 Clinical 
assessment 
No pain 
during 
weight-
bearing 
Ability to bear 
weight 
Ability to perform activities of daily 
living without pain, or no residual pain 
at fracture site, or full range of motion 
at adjacent joint 
 
Shaft fracture  
 Radiographic 
assessment 
Bridging of 
fracture site 
Bridging of 
fracture site 
Bridging of fracture site Bridging of fracture site 
 Clinical 
assessment 
No pain 
during 
weight-
bearing 
No pain during 
weight-bearing 
No pain on palpation/examination No pain on 
palpation/examination 
Distal fracture  
 Radiographic 
assessment 
Bridging of 
fracture site 
Bridging of 
fracture site 
Bridging of fracture site  Obliteration of fracture line 
or calcification of callus 
 Clinical 
assessment 
No pain 
during 
weight-
bearing 
No pain during 
weight-bearing or 
ability to bear 
weight 
No pain on palpation/examination  No residual pain at fracture 
site 
 
A fracture union was classified either on clinical or radiological assessment, or 
both. A non union was defined on the above grounds at 24 weeks for a tibia/femur 
fracture; and 12 weeks for all other fractures.  Non union was established by these 
criteria prior to any further surgery taking place to address the non union.  
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 Wound infection 2.9.6.3
 
Classification of wound infections is controversial. In this project the ASEPSIS  
wound scoring system was used as recommended by the Surgical Infection Study 
Group 200. This system has been used in similar research projects. Use of the same 
system should increase the validity of a comparison between our results and those 
of others. This system scores the appearance of the wound and assesses the 
necessity for further treatment, such as the administration of antibiotics as shown in  
Table 2-2. It is very sensitive and allows objective appraisal of infection, but it 
may not accurately quantify severity of infection.  
The maximum score is 70. For the purpose of our study a score of 0 to 10 was 
considered to represent normal wound healing, a score of more than 10 to represent 
an infection. This confers a sensitive, if arbitrary, definition of infection. The author of 
this thesis personally recorded the scores at 5 days, 2 weeks, 6 weeks and 3 months 
post definitive wound closure. The use of antibiotics 24h post definitive wound 
closure, was considered treatment of underlying infection.  
 
Table 2-2 Describing the ASEPSIS wound infection scoring system 
ASEPSIS wound score 
 Proportion of wound affected,  % 
Wound Characteristic 0 <20 20-39 40-59 60-79 >80 
Serous exudate 0 1 2 3 4 5 
Erythema 0 1 2 3 4 5 
Purulent exudate 0 2 4 6 8 10 
Separation of deep tissues 0 2 4 6 8 10 
 
Additional Points for: 
 
Antibiotic treatment required 10 
Drainage of pus under LA 5 
Drainage of wound under GA 10 
Isolation of bacteria 10 
Stay as an in-patient over 14 days 5 
Total   0-70 
Score >10 suggests wound infection 
 
 Pin-site infection 2.9.6.4
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Assessment of pin sites is less controversial. The scoring system used in similar 
trials was the system described by Checkett201: it was adopted in this series and  is 
outlined as follows: 
 
0: Normal healthy appearance.  
1: Discharge from the pin site.  
2: As 1 with antibiotics given.  
3: As 2 and pin re-sited.  
4: Pin loose and fixator abandoned.  
5: Osteomyelitis in pin track.  
6: Osteomyelitis requiring surgical treatment. 
 
The highest score of the six pins was taken as the patient’s score. This was done 
in conjunction with the asepsis wound scoring system. Due to the controversy 
highlighted in section 1.3.3.7 regarding the method of scoring the pins, it was felt 
most appropriate to take the highest score of the 6 pins on the external fixator, as the 
“pin score”. We used the highest score obtained over the entire use of the fixator 
2.10  Statistical analysis 
 
The analysis of the Binary nominal data was done using the Chi squared test. In 
cases where the expected value was less than 5, then the Fisher’s exact test was 
used. The Mann Whitney test was used to assess differences between the ages of 
different groups. Tests were all two tailed and a p value was used to gauge 
significance. This study is a prospective case control study, and therefore risk ratios 
and corresponding confidence intervals are given where appropriate. When 
describing the statistics in the text, the strength of the association was dependant on 
the p value, cut off values are as described: a p value of 1-0.2 was described as no 
evidence of an association, 0.2-0.05 weak evidence of an association, and <0.05 
strong evidence of an association202. 
In the assessment of multiple potential risk factors, binary logistic regression was 
used. 
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HIV is a progressive disease and it was felt to be important, in proving causality, 
to try identify if any effects of HIV were severity dependant. In order to do this a CD4 
count of 350 (the point at which HAART treatment is often initiated) was used as a 
cut off for advanced and early disease. We have compared the four cohorts, HIV 
negative, HIV positive, Early HIV and Advanced HIV. 
 
2.11 Funding 
 
This project was supported by a research grant from CURE INTERNATIONAL, 
and the Sir Ratanji Dalal Research Scholarship from the Royal College of Surgeons 
London. 
  
80 
 
Chapter 3 
Results 
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3 Results  
3.1 Cohort 1, Open Fractures treated with surgical stabilization 
This data is being analysed to interrogate the following null hypotheses: 
 There are no associations between HIV or advanced HIV and wound 
infection in open fractures treated with surgical stabilization. 
 There are no associations between HIV or advanced HIV and non union in 
open fractures treated with surgical stabilization. 
 
3.1.1 Patients 
Over a 9 month period 133 patients with 135 fractures met the inclusion criteria.  
No patients refused entry into the study. 
3.1.2 Follow up 
97% had follow up of at least 2 months 
89% had follow up of at least 3 months 
The mean length of follow up was 20 weeks with a range of 4-47 weeks. 
4 patients were lost to follow up prior to confirmation of fracture union/non union 
 
Ensuring good follow up was critical to the study. Patients who did not attend their 
appointments were rung on their cell phone and if necessary a repeat appointment 
made for the following week. Due to time constraints it was only possible to ensure 
three month follow up for the final patients recruited. However if union had yet to be 
confirmed the patient was still followed up.  
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3.1.3 Baseline characteristics 
 Patient specific characteristics 3.1.3.1
Figure 3-1 shows the prevalence of HIV within the cohort. 
 
 
Figure 3-1 
  
33, 24% 
86, 64% 
16, 
12% 
Pie Chart showing the prevalence, (numbers , 
percentage) of HIV. 
HIV positive HIV negative Unknown
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Of the 33 HIV positive patients, 6 were taking HAART on admission, of these 4 
underwent internal fixation and 2 external fixation. CD4 counts were available on 26 
patients. All patients with a positive HIV test were offered CD4 counts. Several 
patients refused this test despite repeated counselling. Of those who had their CD4 
count tested, their distribution is shown in Figure 3-2. 
  
 
Figure 3-2 shows that amongst the HIV positive patients there were none with a 
CD4 count result below 100 cells/µL (a sign of very severe disease). Of those who 
accepted testing approximately half the patients were in the advanced group and half 
in the early group. Patients who refused CD4 counts were all young males (less than 
50), who smoked.. In secondary analyses looking at advanced and early HIV, 
patients without CD4 counts were excluded. This may introduce some selection bias 
  
 
Figure 3-2. The cut off for advanced and early HIV is illustrated 
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Table 3-1 shows demographic comparisons between HIV positive, negative and 
those who refused HIV testing. Statistical analysis shown below excludes patients 
whose HIV status was unknown. 
Table 3-1. Showing the demographic comparisons in cohort 1 
 HIV positive 
(%) 
HIV negative 
(%) 
P 
value 
HIV status 
unknown 
Refused 
cd4 counts 
Number of patients 33 86  16 7 
Mean age  32 34 0.86 
MW
 31 27 
Male   
 
28/33          
(81) 
70/86            
(81) 
 13/16 
(81) 
100% 
age<50  31/33           
(94) 
75/86               
(87) 
0.51 
FE
 15/16 
(94) 
100% 
albumin<30  16/33       
(49) 
24/86            
(28) 
0.03 
X
 6/16 
(38) 
60% 
Smoking 
  
21/33         
(64) 
35/85          
(41) 
0.028 
X
 5/15 
(33) 
100% 
MW
 = Mann Whitney, 
FE
 = Fisher Exact, 
X   
= Chi Squared 
 
Table 3-1 highlights that the study group is a predominantly a young male 
population. It also looks at factors which were thought may be important risk factors 
for wound infection and non union and may vary significantly between the HIV 
positive and negative populations.  
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  Injury specific characterisitcs 
Figure 3-3 to Figure 3-6 shows the features of the injuries within cohort 1. 
 
  
 
 
 
Figure 3-4 GSW- Gun shot wounds,  MVA-Motor vehicle accident, PVA – Pedestrian vehicle 
accident 
 
 
 
Figure 3-3 
 
86 
 
 
 
 
 
 
 
 
 
Figure 3-5 
 
Figure 3-6 
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3.1.4 Infection rates 
This study has looked at the association between wound infections and HIV in 
cohort 1. The cohort has been further subdivided into grades of wound, and similar 
analyses have been done on these sub groups. 
 Overall wound infection rates 3.1.4.1
Table 3-2 shows the wound infection rates in the HIV positive and negative 
groups.   
Table 3-2 
Wound Infection, Number, (%) The risk of developing a wound infection given HIV 
infection. 
Risk Ratio = 0.69 (0.3-1.7) 
95% CI
 
P value = 0.4 
 Yes No 
HIV positive 5, (15) 28, (85) 
HIV negative 19, (22) 67, (78) 
 
 The risk of developing a wound infection given 
advanced HIV infection  
Risk ratio 1.28 (0.3-5.09)
95% CI
 
P value = 0.74 
Advanced HIV 4, (27) 11, (73) 
HIV negative 19, (22) 67, (78) 
 
 The risk of developing a wound infection given 
advanced HIV infection  
Risk ratio 0.25 (0.04-1.78)
95% CI
 
P value = 0.18 
Early HIV 1, (6) 17, (94) 
HIV negative 19, (22) 67, (78) 
 
 The risk of developing a wound infection given 
advanced HIV compared to early HIV infection. 
Risk ratio 4.8(0.6-38.5)
95% CI
 
P value = 0.15 
Advanced HIV 4, (27) 11, (73) 
Early HIV 1, (6) 17, (94) 
 
In this cohort, surprisingly patients with HIV have a lower infection risk however 
there is no evidence that this difference is greater than would be expected by chance 
alone. As hypothesized patients with advanced HIV have higher infection rates than 
HIV negative patients although the relative risk is small. There is no evidence that 
this difference is greater than would be expected by chance alone. The data 
unexpectedly suggest that patients with early HIV have a 75% reduction in infection 
rate in comparison to the HIV negative patients, although it only provides weak 
evidence that this difference is greater than would be expected by chance alone. 
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reduced rate of infection The data suggest that patients with advanced HIV have 
high risk of wound infection than patients with early HIV. It provides weak evidence 
that that this difference is greater than would be expected by chance alone. I 
 
 Logistic regression 3.1.4.2
Table 3-3 shows logistic regression analysis looking at potential risk factors for 
wound infection. 
Table 3-3. Logistic regression analysis for wound infection 
 
Adjusted Risk Ratio 
for wound infection 
P value 
High grade wound (Gd 2 or 3) 2.3 0.12 
Delay greater than 24h to debridement 1.7 0.31 
Smoking .5 0.17 
HIV Positive .8 0.64 
 
In this cohort, grade of wound and a prolonged delay to debridement were the 
biggest risk factors for wound infections. Neither HIV infection nor smoking was 
associated with increased risk of wound infection.   
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Table 3-4 shows logistic regression analysis using advanced HIV rather than HIV 
as a risk factor 
Table 3-4 Logistic regression analysis for wound infection 
  
Adjusted Risk Ratio for 
wound infection 
P value 
High grade wound (Gd 2 or 3)  
 
3.0 0.31 
Advanced HIV 
 
2.0 0.31 
 Delay greater than 24h to debridement  
 
1.7 0.37 
Smoking  
 
0.6 0.27 
 
In this cohort, grade of wound and advanced HIV had the strongest effect on 
wound infection.   
 CD4 counts and wound infections 3.1.4.3
CD4 count is a marker of the severity of the immuno-compromise. It is reasonable 
to expect that as CD4 counts fall the risk of infection may increase. Unfortunately 
because the ASEPSIS scoring system is threshold scoring system and as the 
numbers are small, it is not feasible to plot the ASEPSIS score against CD4 count. 
Figure 3-7 shows patients with HIV, with and without wound infection and their CD4 
counts. 
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Using logistic regression analysis, there is a trend towards increasing infection 
rates with lower CD4 counts, however the data provides no evidence that this more 
than would be expected by chance alone, n=26, Risk ratio = 0.998, P value = 0.477. 
Scatter plot showing CD4 counts of the HIV positive patients with and without 
wound infection 
 
Figure 3-7, The dark shading denotes patients with advanced HIV 
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 Subgroup Analysis 3.1.4.4
Table 3-5 shows analysis of wound infection by differing grades of HIV and 
advanced HIV against unexposed.  
Table 3-5.  Sub group analysis by grade of injury (Gustilo-Anderson) for wound infection 
given HIV or advanced HIV infection. 
 Rates of Wound infection, number of patients (%) 
 Abrasions 1 2 3a 3b 
HIV positive 
0/5               
(0) 
4/14         
(29) 
1/9            
(11) 
0/3          
(0) 
0/2         
(0) 
HIV negative 
4/14            
(29) 
3/32           
(9) 
4/17         
(24) 
3/12       
(25) 
4/11     
(36) 
Risk ratio of wound infection 
give HIV positivity, (95% CI) 
NA 
3.1        
 (0.8-11) 
0.47      
(0.5-3.6) 
NA NA 
P value 
FE
 0.53 0.18 0.62 1 1 
 
 
Advanced HIV 
0/2                
(0) 
4/8            
(50) 
0/1 
(0) 
0/2            
(0) 
0/2          
(0) 
HIV negative 
4/14            
(24) 
3/32            
(9) 
4/17 
(24) 
3/12       
(25) 
4/11     
(36) 
Risk ratio of wound infection 
given advanced HIV, (95% CI) 
NA 
5.33 
(1.48-19.2) 
NA NA NA 
P value
 FE
 1 0.02 1 1 1 
 
Advanced HIV 
0/2                
(0) 
4/8            
(50) 
0/1 
(0) 
0/2            
(0) 
0/2          
(0) 
Early HIV 
0/3            
(0) 
0/6            
(0) 
1/8 
(13) 
0/1  
(0) 
0/0      
(-) 
Risk ratio of wound infection 
given advanced HIV, (95% CI) 
NA 
4.2
X
 
 
NA NA NA 
P value
 FE
 1 0.08 1 1 1 
 
The data shows that in grade 1 injuries rates of wound infection are higher in 
patients with HIV and particularly in patients with advanced HIV, when compared 
against both HIV negative and early HIV controls . In  grade 1 injuries this data 
shows weak evidence of an important association between HIV and wound infection, 
but strong evidence of an important association between advanced HIV and wound 
infection. 
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Of note is that in both HIV and advanced HIV infection rates were lower than 
controls in the more severe grade of injury, however due to small numbers there is 
no evidence that this difference is greater than would be expected by chance alone. 
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3.1.5 Grade 1 injuries 
Due to this isolated increased risk of wound infection in the grade 1 sub group, 
separate subgroup analysis was performed to investigate any demographic or 
confounding factor to account for this finding. 
Grade 1 injures were the most common injury in the study accounting for 48% of 
the patients. The management protocol was different to that of the Grade 2 and 3 
injuries as discussed on page 66, in that they were not treated with urgent 
debridement. 
 Delay to initial surgery and infection rate 3.1.5.1
Due to differences in protocol, grade 1 injuries were not taken to theatre for 
urgent debridement, but were placed on day time lists for urgent fixation (if required), 
whilst grade 2 and 3 injuries were taken for urgent debridement. Occasionally delay 
in presentation, or delay in referral from a peripheral hospital meant there was a long 
delay till debridement. Table 3-6 shows the average time to surgery for the differing 
grades of wound. 
Table 3-6. Median delay to initial surgery for differing grade of wounds 
 Delay to surgery/days (Median) 
Grade All patients HIV positive HIV negative 
1 3.5 4 3 
2 1 1.5 1 
3a 0.75 0.5 1 
3b 0.5 0.5 0.5 
 
This table shows that grade 1 injuries on average had a longer wait to theatre 
than the higher grade injuries. Patients with HIV with grade 1 injuries had on average 
a 24 hour longer delay to theatre than HIV negative patients. 
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 Base line characteristics  3.1.5.2
3.1.5.2.1 Patient specific characteristics 
 Figure 3-8 shows the HIV status of the patients with grade 1 injuries 
 
Figure 3-8 
Figure 3-9 shows CD4 counts of the HIV positive patients with Grade 1 injuries 
 
 
Figure 3-9. The cut off for advanced and early HIV is illustrated 
23, 22% 
65, 64% 
14, 
14% 
Pie Chart showing the prevalence, 
(numbers , percentage) of HIV in grade 
1 injuries. 
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 Table 3-7 shows the Demographic comparisons between the HIV positive and 
negative patients with grade 1 injuries. 
Table 3-7 
 HIV positive 
(%) 
HIV negative 
(%) 
P value 
Number of patients 23 65  
Mean age 32 33  
Male  20/23              
(87) 
53/65             
(81) 
0.55 
FE
 
Age<50 21/23             
(9) 
57/65           
(12) 
0.49 
FE
 
Albumin<30  9/23                
(39) 
18/65              
(28) 
0.31 
X
 
Smoking  14/23         
(61) 
27/65         
(41) 
0.09
 X
 
The two groups appear broadly similar, except with regard to smoking. The 
demographics are similar to that seen in the cohort as a whole.  
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3.1.5.2.2 Injury specific characteristics 
Figure 3-10 to Figure 3-12 show the, cause, method of fixation, and location of the 
injuries in grade 1 cohort. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-11 
 
 
Figure 3-10,  GSW – Gun shot wounds, MVA- Motor vehicle accident, PVA-Pedestrian vehicle 
accident 
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 Logistic regression analysis 3.1.5.3
Table 3-8 and Table 3-9 show logistic regression analysis looking at potential risk 
factors for wound infection.  
Table 3-8, Logistic regression analysis of possible risk factors (including HIV infection) for 
wound infection in grade 1 injuries. 
  
Adjusted Risk Ratio for 
wound infection 
P value 
   
HIV Positive 5.0 0.094 
Delay greater than 24h 
to debridement 
1.8 
 
0.62 
 
Smoking 0.438 0.35 
 
Table 3-9. Logistic regression analysis of possible risk factors (including advanced HIV 
infection) for wound infection in grade 1 injuries. 
  
Adjusted Risk Ratio 
for wound infection 
P value 
   
Advanced HIV 19 0.005 
Delay greater than 24h to 
debridement 
1 0.98 
Smoking 0.6 0.70 
  
 
 
Figure 3-12 
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These tables provide suggestive evidence that HIV is associated with wound 
infections in grade 1 injuries, and strong evidence of an association with advanced 
HIV. The data suggests that this is a strong association with an adjusted risk ratio of 
infection given advanced HIV of 19.  
3.1.6 Non union rates 
 Overall non union rate 3.1.6.1
Out of the 119 fractures whose HIV status was known, 4 fractures were lost to 
follow up and were excluded from the following analysis.  
 
Table 3-10 Non union rates in cohort 1 
Non union, Number (%) The risk of developing a non union given HIV 
positivity. 
Risk ratio = 4.1 (1.1-16.3)
95%CI
  
P value
 x
= 0.04  
 Yes No 
HIV positive 5, (15) 28, (85) 
HIV negative 3, (4) 79, (96) 
 
 The risk of developing a non union given advanced 
HIV infection compared to HIV negative controls. 
 Risk ratio = 3.64(0.7-20.0)
95% CI 
 P value
FE
 = 0.17 
Advanced HIV 2, (13) 13,  (87) 
HIV negative 3, (4) 79, (96) 
 
 The risk of developing a non union given advanced 
as compared to early HIV infection. 
 Risk ratio = 0.8 (0.15-4.18)
95% CI 
 P value
FE
 = 1 
Advanced HIV 2, (13) 13,  (87) 
Early HIV 3, (17) 15, (83) 
 
Table 3-10 show that there is good evidence of a strong association between HIV 
infection and the development of non union within the cohort. It  also provides weak 
evidence of a moderate association between advanced HIV and non union when 
compared against HIV negative controls. In addition, it shows that non union rates 
are slightly lower in patients with advanced HIV compared to early HIV, however 
there is no evidence that this difference is greater than would be expected by chance 
alone. 
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 CD4 counts non union 3.1.6.2
Figure 3-13 shows the CD4 counts of those patients with and without non union 
 
 
Scatter plot showing CD4 counts of the HIV positive patients 
with and without non union 
 
Figure 3-13, The dark shading denotes patients with advanced HIV 
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Using logistic regression there is a trend of increasing union rates as CD4 counts 
drop, however the data provides no evidence that this more than would be expected 
by chance alone, n=26,  Risk ratio = 1.001, P value 0.56. 
 Logistic regression  3.1.6.3
Table 3-11 and Table 3-12 show logistic regression analysis with relevant 
potential risk factors. 
 
Table 3-11, Logistic regression analysis of possible risk factors for non union  
 
Adjusted Risk Ratio 
for non union 
P value 
High Grade wound 
 
15 0.02 
HIV Positive 
 
6 0.05 
Delay to surgery > 24h 
 
2 0.44 
Smoking 1 0.97 
 
Table 3-12, Logistic regression analysis of possible risk factors for non union using 
advanced HIV as a risk factor  
 
Adjusted Risk Ratio 
for non union 
P value 
High Grade wound 
 
6.1 0.06 
Advanced HIV 
 
2.5 0.3 
Delay to surgery > 24h 
 
1.2 0.8 
Smoking 1.6 0.5 
 
 
Table 3-11 suggests that in this study HIV was strongly associated with the 
development of non union. It also provides strong evidence against the null 
hypothesis that HIV is not associated with non union. Table 3-12 suggests that 
advanced HIV is associated with an increased risk of non union, although smaller 
than that seen with HIV infection. It provides weak evidence to reject the null 
hypothesis that advanced HIV is not associated with non union. This may be due to 
the small numbers of patients present in this group of patients. 
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3.2 Cohort 2: Open fractures fixed by internal fixation 
This study has examined the rates of wound sepsis and union rates within cohort 
2 in order to investigate the following null hypotheses: 
 There is no association between HIV or advanced HIV and wound 
infection in open fractures treated with internal stabilization. 
 There is no association between HIV or advanced HIV and non union in 
open fractures treated with internal stabilization. 
3.2.1 Patients 
Over a 9 month period 102 patients with 103 fractures met the inclusion criteria.  
3.2.2 Follow up 
96% had follow up of at least 2 months 
88% had follow up of at least 3 months 
Mean length of follow up 20 weeks, range 4-47 weeks 
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3.2.3 Baseline characteristics 
 Patient related factors 3.2.3.1
Figure 3-14 shows the prevalence of HIV within the cohort. 
 
Figure 3-14 
4 HIV positive patients were taking HAART, the majority of the remaining HIV 
positive patients were not aware of their HIV status on admission to hospital.  
Of the 23 HIV positive patients CD4 counts were available on 17 patients; their 
distribution is shown in Figure 3-15 :   
23, 22% 
65, 64% 
14, 
14% 
Pie Chart showing the prevalence, 
(numbers , percentage) of HIV. 
HIV positive HIV negative Unknown
 
Figure 3-15.  The cut off for advanced and early HIV is illustrated  
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Table 3-13   shows demographic comparisons made only on patients whose HIV 
status was known 
Table 3-13   
 HIV positive 
(%) 
 
HIV negative 
(%) 
 
P value 
Number of 
patients 
23  
(27) 
65 
(73) 
 
Mean age  32 33  
Male  20/23 
(87) 
53/65 
(81) 
0.55 
FE
 
Age<50  21/23 
(91) 
57/65 
(88) 
0.49 
FE
 
albumin<30  9 /23 
(39) 
18/65 
(28) 
0.31 
X
 
Smoking  14/23 
(61) 
27/65 
(41) 
0.094
 X
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 Injury related factors 3.2.3.2
Figure 3-16 to Figure 3-19 show the cause, method of fixation, grade and location 
of the injuries.  
 
 
 
 
 
Figure 3-17 
 
Figure 3-16 
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Figure 3-18 
 
 
Figure 3-19 
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3.2.4 Infection rates  
This study has looked at the association between wound infections and 
HIV in cohort 2. The cohort has been further subdivided into grades of 
wound, and similar analyses have been done on these sub groups. 
 Overall wound infection rate 3.2.4.1
Table 3-14 shows the wound infection risk in patients treated with internal fixation. 
Table 3-14 
Wound Infection, Number, (%) The risk of developing a wound infection given HIV 
infection. 
RR= 0.85 (0.3-2.8)
95% CI
  
P value 
FE
 = 1 
 Yes No 
HIV positive 3, (13) 20, (87) 
HIV negative 10, (15) 55, (85) 
 
 The risk of developing a wound infection given 
advanced HIV infection. 
RR= 2.17 (0.73-6.42)
95% CI
 
 P value 
FE
 = 0.19 
Advanced HIV 3, (33) 6, (67) 
HIV negative 10, (15) 55, (85) 
 
 The risk of developing a wound infection given 
advanced HIV compared to early HIV infection. 
Risk ratio =NA 
P value
FE
 = 0.04 
Advanced HIV 3, (33) 6, (67) 
Early HIV 0, (0) 16, (100) 
In patients treated with internal fixation, patients with and without HIV have 
a similar wound infection risk. As hypothesized patients with advanced HIV 
have higher infection rates than controls, this data provides weak evidence 
that that this difference is greater than would be expected by chance alone. 
The data suggest that patients with advanced HIV have an increased risk 
of wound infection than patients with early HIV. It provides strong evidence 
that that this difference is greater than would be expected by chance alone.  
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 Logistic regression analysis 3.2.4.2
Table 3-15 and Table 3-16  shows logistic regression analysis looking at HIV and 
advanced HIV are associated with wound infection. 
Table 3-15. Logistic regression analysis for wound infection, using HIV as a risk factor, 
within cohort 2 
 Adjusted Risk ratio P value 
   
Delay of greater than 24 hours to 
debridement 
1.6 0.57 
High grade wound 1.2 0.57 
HIV infection 0.9 0.93 
Smoking 0.5 0.27 
 
Table 3-16. Logistic regression analysis for wound infection using advanced HIV infection 
as a risk factor, within cohort 2 
 Adjusted Risk ratio 
 
P value 
   
Advanced HIV  4.1 0.08 
High grade wound 1.4 0.67 
Delay of greater than 24 hours to 
debridement 
1.2 0.89 
Smoking 0.4 0.57 
This analysis shows that in this cohort HIV is not associated with wound infection, 
when adjusted for the above confounders. Advanced HIV is associated with a four 
times increased risk of wound infection, and the data provides moderate evidence 
against the null hypothesis that advanced HIV is associated with wound infection in 
open fractures treated with internal stabilization. 
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 CD4 counts and wound infections 3.2.4.3
Table 3-16  suggests that a declining CD4 count might lead to an increased risk 
of wound infection. Figure 3-20 is a scatter plot showing the CD4 counts of the HIV 
positive patients and whether or not they developed infections. 
 
Using logistic regression there is a trend of increasing union rates as CD4 counts 
drop, however the data provides no evidence that this more than would be expected 
by chance alone, n=13,  Risk ratio = 0.99, P value 0.31.  
  
Scatter plot showing the CD4 counts of the HIV positive patients 
and whether or not they developed infections 
 
 
Figure 3-20 
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 Subgroup Analysis 3.2.4.4
 Table 3-17 shows analysis of wound infection by differing grades.  
  
Table 3-17. Sub group analysis by grade of injury (Gustilo-Anderson) for wound infection 
given HIV or advanced HIV infection, within cohort 2. 
 Rates of Wound infection, number of patients (%) 
 Abrasions 1 2 3a 3b 
HIV positive 
0/5 
(0) 
3/12 
(25) 
0/5 
(0) 
0/0 0/1 
(0) 
HIV negative 
4/14 
(29) 
2/30 
(7) 
1/12 
(8) 
2/7 
(29) 
1/2 
(50) 
Risk ratio of wound infection 
give HIV positivity, (95% CI) 
NA 3.8 NA NA NA 
P value 
FE
 0.53 0.13 1 NA 1 
 
 
Advanced HIV 
0/2 
(0) 
3/6 
(50) 
0/0 0/0 0/1 
(0) 
HIV negative 
4/14 
(29) 
2/30 
(7) 
1/12 
(8) 
2/7 
(29) 
1/2 
(50) 
Risk ratio of wound infection 
given advanced HIV, (95% CI) 
NA 7.5 NA NA NA 
P value
 FE
 1 0.02 NA NA 1 
 
 
These data shows that in HIV positive patients, internally fixed fractures with 
grade 1 injuries have an increased risk of infection compared to HIV negative 
controls. This difference is increased in advanced HIV. This data provides strong 
evidence that advanced HIV is associated with wound infection in grade 1 injuries. 
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3.2.5 Radiological non union 
 Overall non union risk 3.2.5.1
Out of the 88 fractures whose HIV status were known, 3 fractures were not 
followed to union/non-union and are therefore excluded from the following analysis. 
Table 3-18 shows the risk of non union within the cohort. 
 
Table 3-18, Risk of non union in cohort 2 
Non union, Number (%) The risk of developing a non union given HIV 
positivity. 
Risk ratio = 2.7 (0.2-41)
95%CI
  
P value 
FE
= 0.47 
 Yes No 
HIV positive 1, (4) 22, (96) 
HIV negative 1, (2) 61, (98) 
 
There were no significant differences in risk of non union between the HIV 
positive and negative patients. Due to the low numbers of non-unions both sub group 
analysis and logistic regression was not possible. 
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3.3 Cohort 3: Open fractures treated by external fixation  
3.3.1 Introduction 
This data is being analysed to interrogate the following null hypotheses: 
 That there is no association between HIV or advanced HIV and pin site 
sepsis in open fractures treated with external fixation. 
 That there is no association between HIV or advanced HIV and non union 
in open fractures treated with external fixation 
3.3.2 Patients 
Over the 9 month period 32 patients with 32 fractures met the inclusion criteria. 
3.3.3 Follow up 
All patients were followed up until union/non union.  
Mean length of follow up 20 weeks, range 10-36 weeks 
3.3.4 Baseline characteristics 
 Patients specific 3.3.4.1
Figure 3-21 shows prevalence of HIV within the cohort  
 
Figure 3-21 
10, 31% 
21, 66% 
1, 3% 
Pie chart showing HIV status (numbers and %) 
of patients with external fixation of the fracture 
 HIV positive HIV negative Unknown
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CD4 counts were available for 9 out of the 10 patients. Their distribution is shown 
in Figure 3-22 
 
 
Table 3-19 show the demographic comparison in the patients with whom the HIV 
status was known. 
Table 3-19 
 HIV positive 
(%) 
HIV negative 
(%) 
P value 
Number of patients 10 
(32) 
21 
(68) 
 
Mean age 31 36 0.77
MW
 
Male % 80 86 0.53
FE
 
Age<50   10/10 
(100) 
18/21 
(86) 
0.3
FE
 
Albumin<30  7/10 
(70) 
6/15 
(29) 
0.036
FE
 
Smoking 7/10 
(70) 
9/21 
(43) 
0.15
FE
 
  
 
 
Figure 3-22 
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 Injury specific 3.3.4.2
Figure 3-23 to Figure 3-25 show the grade, cause and location of the injuries.  
 
 
Figure 3-23 
 
 
 
Figure 3-24 
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Graph showing the % and number of HIV 
positive/negative patients treated by external 
fixation sustaining the injury.  
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Graph showing the % and number of HIV 
positive/negative patients treated by external 
fixation with fractures of each bone 
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Figure 3-25 
 
Forearm external fixators were all Orthofix Pennig, using a total of 4 pins. Tibia 
external fixators used were: Orthofix monolateral, AO monolateral and AO hybrid. 
Monolateral tibia external fixators used 6 pins. 
Grade 1 injuries were uncommonly treated by external fixation unless 
contaminated or the fracture pattern necessitated it. 
External fixators remained insitu until the fracture healed, or a deterioration in the 
pin/wire bone interface, necessitated removal. The mean length of time for the fixator 
to remain in situ was 13 weeks in the HIV positive group and 12 weeks in the HIV 
negative group. 
  
2 
4 
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1 2 
5 5 
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%
 
Graph showing the % and number of HIV 
positive/negative patients treated with external 
fixation with differiing grades of wound. 
HIV positive HIV negative
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3.3.5 Pin-site infection 
Figure 3-26 shows the maximum Checketts grade obtained from any of the pin 
sited for the duration of the external fixators application. 
 
Figure 3-26 
 
Table 3-20 shows statistical analysis on patients who required antibiotics, or 
removal of their external fixator due to infection (Checketts>=2). 
Table 3-20 
 Checketts score >=2 
(%) 
The risk of a pin site infection (>=2) given 
HIV infection 
 
Risk Ratio = 0.9 (0.5-1.6)
95% CI
 
P value
FE
= 1 
 
HIV infection Yes No 
HIV positive 
6/10  
(60) 
4/10  
(40) 
HIV negative 
14/21 
 (67) 
7/21  
(33) 
 
Advanced HIV The risk of a pin site infection (>=2) given 
advanced HIV infection 
 
Risk Ratio = 1.0 (0.1-10.4)
95% CI
 
P value
FE
=1 
 
Advanced HIV 
4/6  
(67) 
2/6  
(33) 
HIV negative 
14/21 
 (67) 
7/21  
(33) 
 
3 
1 
3 3 
5 
2 
9 
5 
0
10
20
30
40
50
0 1 2 4
% 
Maximum Checketts grade 
Graph showing the % and number of HIV 
positive/negative patients against highest 
checketts grade.  
HIV positive HIV negative
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Table 3-21 shows statistical analysis on patients who required removal of their 
external fixator due to infection (Checketts=4). 
 
Table 3-21, showing risks of severe pin site sepsis in cohort 3 
 Checketts score =4 
(%) 
The risk of a pin site infection (=4) given 
HIV infection 
 
Risk Ratio = 1.26 (0.4-4.3)
95%CI
  
P value
FE
= 1 
 
 
Yes No 
HIV positive 
3/10  
(30) 
7/10  
(70) 
HIV negative 
5/21 
 (24) 
16/21  
(76) 
 
 
The risk of a pin site infection (=4) given 
advanced HIV infection 
 
Risk Ratio = 2.1 (0.23-47.1)
 95%CI
 
P value
FE 
= 
 
0.55 
 
Advanced HIV 
2/4  
(50) 
2/4  
(50) 
HIV negative 
5/21 
 (24) 
16/21  
(76) 
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 Logistic regression analysis 3.3.5.1
Table 3-22 Logistic regression analysis for pin site infection using HIV infection as 
a risk factor . Table 3-23 Logistic regression analysis for pin site infection using 
advanced HIV infection as a risk factor  
Table 3-22 Logistic regression analysis for pin site infection using HIV infection as a risk 
factor  
 
Adjusted Risk ratio 
for pin site infection 
P value 
HIV infection 0.7 0..9 
High grade wound 0.9 1 
Delay of greater then 24 hours to 
debridement 
0.1 0.1 
Smoking 0.7 0.7 
 
Table 3-23 Logistic regression analysis for pin site infection using advanced HIV infection 
as a risk factor  
 
Adjusted Risk ratio 
for pin site infection 
P value 
Advanced HIV 1.5 0.8 
Delay of greater then 24 hours to 
debridement 
0.02 0.09 
Smoking 0.7 0.5 
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3.3.6 Non-unions  
External fixation is used for patients with severe fractures, with significant soft 
tissue injury, there being often severe contamination and extensive periosteal 
stripping. These patients are therefore at high risk of developing non union. The risk 
of developing non union is shown in Table 3-24. 
Non Union, Number, (%) The risk of developing a wound infection given HIV 
positivity. 
RR= 4 (0.59-16)
95% CI
  
P value 
FE
 = 0.3 
 Yes No 
HIV positive 3/10 (30) 7/10 (70) 
HIV negative 2/20 (14) 18/20 (86) 
Table 3-24 
 Logistic regression analysis 3.3.6.1
Table 3-25 and  
Table 3-26 show logistic regression analysis looking at potential risk factors for 
non union. 
Table 3-25 Logistic regression analysis for non union, using HIV as a risk factor, within 
cohort 3 
 Adjusted Risk ratio P value 
   
HIV infection 10 0.07 
Delay of greater than 24 
hours to debridement 
2 0.4 
Smoking 0.8 0.9 
High grade wound 100 1 
 
Table 3-26- Logistic regression analysis for non union, using advanced HIV infection as a 
risk factor, within cohort 3. High grade wound removed, due to inadequate numbers 
 Adjusted Risk ratio P value 
   
Advanced HIV 5 0.2 
Delay of greater than 24 
hours to debridement 
3.4 0.3 
Smoking 2.4 0.4 
 
 Summary of the patients who developed non 3.3.6.2
union with external fixation 
Two patients who were HIV negative developed non unions: 
1. 60 year old male who sustained a grade 3b tibia fracture following an 
assault. He was not a smoker but did confess to heavy alcohol 
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consumption, and was malnourished with an albumin of 21. He was 
treated with an external fixator but developed sepsis and subsequent non 
union. This was treated with closed IM nailing and he went on to union.  
2. 65 year old male he sustained a close range shot gun injury to his distal 
forearm. He had a massive soft tissue injury and amputation of the hand 
was initially considered. He underwent external fixation, with vac dressing. 
Then delayed skin grafting when the risk of infection was thought to have 
diminished. He developed a fibrous non-union of the radius, but due to the 
massive soft tissue and nerve injury this was not painful. He therefore did 
not undergo further treatment  
  
Three patients in the HIV positive group: 
1. 32 year old male, smoker, who suffered multiple high energy gun shot 
wounds to femur and forearm. His CD4 count was 443 on admission. His 
femur was nailed and united, his radius was treated with external fixation, 
at 4 months there was no evidence of callus on radiographs, however he 
suffered from few symptoms and therefore no further surgery was planned. 
2. 33 year old male, non smoker who sustained a grade 2 tibia fracture 
following a fall from his bike. He was diagnosed with HIV on admission to 
hospital and was noted to have a CD4 count of 509 cells/µL. He underwent 
external fixation. He developed worsening pin site and wound sepsis over 
the next 3 months which did not settle with antibiotics, and the fracture 
drifted into valgus. He refused to return to the hospital after 4 months when 
infected non union was diagnosed, and the Ex Fix removed but he was 
contacted via telephone at six months, and remained unable to put weight 
through this leg. 
3. 26 year old male who was a smoker, who sustained a 3b tibia fracture 
following a wall falling on to his leg. He was diagnosed with HIV on 
admission to hospital, and was found to have a CD4 count of 207 cells/µL. 
He was treated with a fascio-cutaneous flap, and external fixation. Despite 
no evidence of sepsis he failed to unite, and underwent delayed closed IM 
nailing at six months post injury. He united following this intervention. He 
had at this stage been started on HAART   
120 
 
 Time to radiological union 3.3.6.3
Time to radiological union as defined as the presence of bridging callus visible on 
radiographs, were similar in both HIV positive and negative patients, 15 and 16 
weeks respectively. Small numbers and variable dates of clinic appointments made 
subgroup analysis, on location and grade of injury impossible. 
3.4 Patients whose treatment was affected by HIV 
All patients were carefully assessed at the time of treatment and all notes were 
reviewed to see if there was any indication if HIV status had influenced 
management. The only patient who would have been managed with intramedullary 
nailing according to the protocol discussed on page 69, had a fracture that was too 
low for intramedullary nailing and was therefore treated with a hybrid external fixator. 
3.5 Patients with missing data 
3.5.1 HIV test 
There were 16 patients who refused HIV testing, 81% were followed up for at 
least 3 months. There were no cases of superficial wound infection. 2 patients had 
problems with bone healing. One patient sustained a GSW to the mid shaft radius 
and ulna treated with an external fixator, he developed a painless non-union of the 
radius 6 months later. The other patient sustained a grade 1 injury of the radius and 
ulna, treated with locking plates. The ulna locking plate pulled off and she required 
repeat surgery and bone grafting. 
3.5.2 CD4 result 
There were 7 HIV positive patients for whom CD4 counts were not available. 
These patients all went on to union without any incidence of wound infection. 
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Chapter 4  
Discussion 
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4 Discussion 
4.1 Methods 
This study was a prospective observational cohort study. The study design and 
the environment that the study was conducted in presented many challenges and 
introduced many potential sources of error. 
4.1.1 Selection Bias 
This was a cohort study that selected all contiguous admissions with open 
fractures in adults. Exclusion criteria were designed to exclude patients who would 
be difficult to follow up, or who had major poly-trauma that management was difficult 
to standardize. It was felt unlikely that any of these criteria would have introduced a 
significant selection bias.  
4.1.2 Lack of blinding altering management 
The lead clinician was not blinded to HIV status but review of the notes suggests 
that no patient management was altered as a result of HIV status, and that 
management was based on the treatment protocols. Despite this it remains possible 
that small management changes were made as a result of HIV status, perhaps 
favouring treatment external fixation over internal fixation. The data suggests that 
patients who were HIV positive were more likely to be treated by external fixation 
than HIV negative patients( 30% vs 24%). Previous work has suggested that the risk 
of non union is higher in fractures fixed by external fixation in comparison to IM 
nailing54. This differential bias has occurred it may lead to an increased observed risk 
of non union in the HIV positive patients.  
4.1.3 Lack of Randomization 
This study was an observational study and therefore no randomization took place. 
It is therefore not possible to answer the question, “Is internal or external fixation the 
best method of fixation for open fractures in HIV positive patients?”. To answer this 
question would require a separate trial. 
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4.1.4 Measurement Bias 
An attempt to limit the subjectivity of the scoring systems of wound infection and 
pin-site sepsis was made in this study. The outcome measures used still have a 
degree of subjectivity in their assessment. Due to the lack of blinding in the 
assessment of wound and pin sties it is possible despite all the precautions taken 
that this subjectivity could have influenced the results leading to a differential bias.  
Local validation of the individual assessment tools was not conducted. It is 
therefore possible that this may have introduced an additional source of bias. 
4.1.5 Application to other populations 
The study hospital was a government hospital, in a Zulu rural community and 
predominantly took patients engaged in unofficial employment and without health 
insurance. These were generally patients from lower socioeconomic groups. This 
group of patients may have higher prevalence of HIV and higher rates of trauma than 
the general population.  
The subtype of HIV seen in this study is C, this is different to that seen in 
population in Europe and North America which is B.  
These factors may have implications with applicable of this trials results to other 
populations. 
4.1.6 Patient related factors 
The prevalence of HIV was 22%, this is lower than expected, given the 
prevalence in pre natal checks in women in the area. This may be explained by the 
male preponderance (81%) of the study population. It has been shown that women 
have higher prevalence of HIV than men: this is attributed to sexual behaviour, and 
transmission routes203.   
Comparison of the demographic data of the cohorts revealed several differences. 
Patients with HIV were more likely to be smokers with a p value=0.028. Smoking is 
known to be a risk factor for non-union78. It is possible that patients with HIV are 
more likely to smoke, due to an increased risk taking behaviour, and therefore 
smoking should not be treated as a confounder. Although patients were all 
counselled about the need to try to stop smoking, very few changed their behaviour. 
It was not possible to accurately quantify the numbers patients smoked. Financial 
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constraints meant that most patients bought cigarettes one at a time, smoking more 
around pay day, and relatively few for the rest of the month. Smoking has been used 
in the logistic regression analysis however its significance needs to be interpreted 
with caution. 
HIV infection was also associated with higher levels of hypoalbuminaemia. 
Patients with HIV are known to have an increased rate of hypoalbuminaemia and 
this is also known to be a risk factor for non union. This is therefore considered to be 
on the causal pathway and is not used in logistic regression analysis. 
In at least one patient it was considered likely that the domestic abuse in which 
she sustained a grade 3 forearm fracture may have been related to her HIV 
diagnosis. This effect was not thought to be widespread, but could lead to an 
alteration of the study population.  
On comparison of the grades of wounds between the HIV positive and negative 
patients, the groups are broadly similar with a slightly increased percentage of 
grade3 injuries in the HIV negative group. It was therefore not felt that the 
phenomena noted above significantly altered our outcomes.  .  
4.1.7 Injury specific factors 
The location of the injury is varied, with open tibia fractures being the most 
common; this is similar to previous studies. The high number of forearm fractures is 
secondary to the high level of domestic abuse where these injuries are commonly 
inflicted by bush knives. These injuries most often occur in females, often include 
tendon and nerve injuries and were in one instance bilateral. This has obvious 
repercussions with hygiene and rehabilitation. 
HIV positive patients proportionally have fewer grade 3 open fractures. This 
should lead to a slight bias favouring a higher union rate in the HIV positive group.  
During the period of the study, no grade 3c fractures were admitted with a viable 
limb. This is probably a result of the often long time delay between injury and arrival 
at hospital.  
The huge variety of severity and mechanism of injury, being categorised into such 
broad categories (Gustilo Anderson classification) was a significant limitation of this 
study. Clinical studies into open fractures and HIV, have to date been unable to 
compare like for like injuries, because of the relative infrequency of the injuries.  
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Fractures in this study have been treated through a variety of mechanisms; the 
methods of internal fixation are varied and may have implications on union rate. It is 
possible that HIV infection may be more relevant in certain types of fixation such as 
reamed intramedullary nailing. Due to the small numbers of patients in the study and 
the variety of types of injury, it is not possible to comment on the effect of type of 
internal fixation on union rates in these patients. 
4.1.8 Short follow up 
Due to the time constraints associated with this type of study, we do not have the 
data available from long term follow up.  
The incidence of delayed sepsis is critically important in guiding initial treatment 
decisions. This data is being collected, in ongoing work set up by the author. It will 
be several years before this will be ready for analysis.  
It is still a widely held belief that HIV positive patients are at much higher risk of 
delayed sepsis. There is little published evidence to support this, and recently some 
evidence to dispute it131, but there is a biologically plausible explanation, and much 
practice in this area remains based on local expert opinion. 
In this study non unions have been classified as a fracture requiring a repeat 
operation to stimulate bone healing, once a reasonable period of time has elapsed. 
This was 6 months for a tibia/femur fractures or 3 months for other fractures. It is 
acknowledged that other studies would only classify a fracture as a non union, after 
multiple fracture stimulating procedures and a much longer period of time, this study 
was constrained by time limitations. 
4.1.9 Assessment of time union 
It was difficult to ensure regular follow up, especially as patients neared union and 
were beginning to mobilize without pain. Radiographs were also not always available 
at each visit, due to staffing problems, and long waits. Patients would come back if 
asked, but at a time that suited them. It was therefore difficult to consistently 
ascertain a precise time to union. It would be an interesting aspect of a larger study 
to look at time to union in similarly classified fractures 
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4.1.10 Small numbers 
Patient numbers in this study, although greater than in previous studies, were 
small, and therefore it is at risk of a type 2 error. The incidence of HIV was lower 
than expected, and therefore the study did not achieve the numbers required by the 
power study in the external fixation cohort. Ideally this study should guide further 
research, to give the result more statistical validity.  This could include a metanalysis 
with previous work done by Harrison et al.. 
4.1.11 Low CD4 counts: 
No patients with a CD4 counts below 100 cells/µL were seen in this study. The 
results may not accurately represent this group of severely immuno-compromised 
patients. 
4.1.12 Loss to follow up 
The follow up rates in this study were high, in the internal fixation group they were 
88% at 3 months or radiological union and in the external fixation group they were 
100%. Several issues made ensuring follow up more challenging. The catchment 
area for the hospital was an area half the size of Scotland, and we had very little 
funding available to assist with transport costs. The increasing availability of mobile 
phones meant that we were able to maintain contact with the patients, and minimize 
the need to travel to the hospital. A small proportion of patients were either difficult to 
contact or refused to come back to the hospital, these patients were from a varied 
background, and it is not thought that it would have significantly affected the 
outcome of the study 
4.1.13 Missing HIV/CD4 Data  
It was not possible to obtain a full data set, with regard to HIV tests and CD4 
counts. HIV remains a very controversial disease in South Africa, with many social 
and economic implications. It carries with it a stigma which affects both staff and 
patients. Over the last few years there seems to be increasing numbers of patients 
willing to have the HIV test, this is probably driven by the increasing availability of 
HAART. Patients were offered HIV testing on admission, on discharge and all 
subsequent clinic visits. 
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One logistical problem presented an unexpected problem with regard to obtaining 
CD4 counts. In the catchment area of the hospitals, it was common for patients not 
to know their exact date of birth and names were often similar, therefore the hospital 
number and the patient’s national identification (ID) number were both important 
form of identification. HIV services often required co-ordination between health 
facilities and a move had been made to use the national identification number for 
CD4 counts and viral loads. Patients were often unaware of their national ID number 
and this led to several episodes when the lab refused to process samples, whilst 
patients obtained their ID number 
It has been carefully considered whether the missing data from both the HIV tests 
or the CD4 counts could have lead to a selection bias. 44% of the patients who 
refused HIV tests sustained injuries from gun shot wounds. The combination of the 
social circumstances leading to the injury, and psychological impact of the injury, 
may make subsequent HIV test refusal more likely. Of those who refused HIV testing 
there were no cases of wound infection and two patients (13%) had problems with 
bone healing as shown on page 120. It is possible that this group of patients is less 
likely to be compliant with rehabilitation advice, and therefore be at higher risk of 
adverse events.  
Patients, for whom a CD4 count was not available, were included in the overall 
analysis, but excluded when considering the effect of advancing HIV. It is thought 
that the CD4 counts of these patients is likely to be evenly distributed, and should 
have little effect on the overall result. 
4.1.14 Summary 
Many of the limitations of this study are limitations that have been seen in other 
previous studies looking at this type of population. Whilst all results need to be 
interpreted in view of these significant limitations, this study remains the largest 
clinical study on this population group.    
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4.2 Results 
4.2.1 Summary of key results 
Based on the data from this study there is no evidence to reject the null 
hypothesis that there is no association between HIV (or advanced HIV) and wound 
infection in open fractures treated with surgical stabilization. 
Sub group analysis has highlighted that patients with grade 1 injury have a higher 
risk of infection if HIV positive. The data provides weak evidence of an association 
between HIV and wound infection in this group. Stronger evidence is seen with 
advanced disease. 
A similar trend is seen in patients treated with internal fixation. 
This study provides strong evidence to reject the null hypothesis that HIV is not 
associated with non union in fractures treated with surgical stabilization. The 
evidence is weaker for advanced disease. This trend is also seen in patients treated 
with external fixation and provides weak evidence to reject the null hypothesis that 
HIV is not associated with non unions in open fractures treated by external fixation. 
This study provides no evidence to reject the null hypothesis that neither HIV nor 
advanced HIV are associated with pin site sepsis. 
4.2.2 Wound Infection 
Section 3.1 shows that the risk of infection was similar in both the HIV positive 
and negative patients. This was unexpected, previous studies had suggested much 
higher risks of infection in HIV positive patients. The risk of infection increased 
slightly in the patients with advanced HIV, compared to both HIV negative and 
patients with early HIV, the difference remains small with a p value of 0.049.  
Interestingly the wound infection rate was lowest in patients with early HIV, with 
relative risk of 0.25 when compared to HIV negative patients.  
It seem likely that in patients with severe immunosuppression secondary to HIV, 
infection rate are likely to increase, this would correlate with increases rates of other 
bacterial infection seen in patients in HIV and discussed in section 1.3.5. It is 
however unexpected that patients with early HIV should have  reduced infection 
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rates when compared to HIV negative patients. Whilst it is possible this observation 
has occurred by chance alone, it is interesting to speculate if it could be possible that 
HIV in its early stages could be beneficial to wound healing. All previous laboratory 
based studies identified have suggested that HIV would be detrimental to wound 
healing9,148-151. One possibility is that the body’s response to trauma is dampened by 
HIV, leading to a reduction in serous exudate and erythema, in patients with only 
mild immunosuppression this may not hinder the healing process, in patients with 
more advanced immuno-suppression it may lead to wound breakdown or bacterial 
infection. This hypothesis would need to be tested in further research 
 
Subgroup analysis shows a strong association in grade 1 open fractures between 
HIV and wound infection. This maybe the result of the different management 
protocols in place for the management of grade 1 fractures. This led to grade 1 
injuries having an increased time to debridement, less extensive debridement and a 
shorter course of antibiotics (due to shorter time to definitive fixation) in comparison 
to the higher grade injuries. Patients with HIV and grade 1 injuries did on average 
wait one day longer than patients who were HIV negative. This could introduce a 
selection bias. 
 A previous study looking at the optimal management of open fractures in HIV 
negative patients has suggested that the risk of infection in grade 1 open injuries 
treated with antibiotics remain low, with and without urgent debridement44.  
One possible mechanism for the above observation would be that in the immuno-
competent patient, the relatively small inoculums from a grade 1 injury is adequately 
controlled by the immune response and antibiotic administration. In the immuno-
deficient patient the immune response is inadequate, and if the inoculum is left insitu 
the bacteria are able to proliferate, leading to a wound infection. This may be 
mediated as a result of increasing numbers of dysfunctional macrophages and 
lymphocytes, which have been shown to be important in wound healing as discussed 
on page 40. Again this hypothesis needs to be tested in further research 
Other notable observations were: 
 Logisitc regression analysis showed that in this cohort, a high grade wound 
was the greatest risk factor for infection ( 3 fold), followed by advanced HIV 
(2 fold). 
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 The risk of infection for fractures associated with abrasions was higher in 
those without HIV than those with HIV. A possible explanation for this is 
that patients with HIV mount a smaller inflammatory response to trauma. 
This manifests as reduced exudate forming over the abrasions (a clinical 
observation), and leads to lower levels of infected exudate, which would 
qualify as wound infection on the ASEPSIS scoring system.  
 Table 3-5 shows how in HIV negative patients the risk of wound infection 
increase as the grade of wound increased, as would be expected from 
previous studies1. The reverse trend is seen in HIV positive patients. The 
numbers are very small and this may have occurred by chance. Table 3-2 
and Table 3-14 show that patients with early HIV have the lowest infection 
rates when compared with advanced HIV and HIV negative patients. The 
question arises; could HIV be beneficial to wound healing in severe soft 
tissue injuries? This would require further investigation. All previous 
laboratory based studies identified have suggested that HIV would be 
detrimental to wound healing. It is possible that the assessment of wound 
infection may be affected by HIV. One of the assessment criteria is the 
formation of a serous or purulent exudate and erythema, it is possible that 
HIV infection may dampen down the expression of exudate or erythema 
following injury and lead to a reduction in severity of the apparent wound 
infection. 
 Although wound infection was more common in the HIV positive patients 
with grade 1 injuries, the majority of infections settled with antibiotics. Only 
four patients, out of the nine who developed non union, had a wound 
infection as a potential risk factor for non union. It should be noted that a 
superficial wound infection, whilst undesirable, is often not detrimental to 
outcome. 
4.2.3 Non union 
Table 3-11 showed that in this study HIV was strongly associated with the 
development of non union with an adjusted risk ratio of 15. It also provided strong 
evidence against the null hypothesis that HIV is not associated with non union with a 
p value of 0.04. Table 3-12 suggests that advanced HIV does not lead to an 
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increased incidence of non union, so providing little evidence to reject the null 
hypothesis that advanced HIV is not associated with non union. This maybe due to 
the small numbers of patients present in this group. 
The incidence of non union was low in patients treated with internal fixation. This 
is likely to be due to selection bias, with the internal fixation cohort recruiting the less 
severe injuries, and making direct comparison with external fixation impossible. 
The incidence of non union in the external fixation cohort followed the same trend 
as the combined cohort. The numbers are smaller and therefore the power of the 
statistical tests is reduced. 
The variety of injuries seen in this study is huge and the classification of the 
injuries remains very broad. It is notable that despite this very broad categorization 
the HIV negative patients did appear to have the more severe injuries, yet still had 
an improved outcome when compared to the HIV positive patients.  
The data from this study suggests the fracture healing is affected by HIV and that 
it is possible that this may be an important factor even in early HIV infection. In the 
introduction, a variety of postulated theories for HIV’s interaction with bone healing 
have been proposed, and any combination of these could lead to the effect observed 
in this trial. It is interesting that some recent research has suggested that loss of 
functioning lymphocytes might lead to improved fracture healing14. There is some 
evidence to suggest that macrophages play an important role in fracture healing. The 
loss of functioning macrophages may result in problems in fracture union. Could this 
interplay between dysfunctional macrophages and lymphocytes account for the 
observed results in this study? 
This study was unable to provide any statistically valid data on time to union. 
There are many factors that affect time to unions, in order to minimize these factors 
a case control study, looking at internally fixed lower limb fractures, with assessment 
of radiological union with monthly radiographs.  
4.2.4 Pin site sepsis 
In this study there is little difference in the risk of pin site infection in the HIV 
positive and negative patients. The biggest difference noted in this study is the risk of 
severe pin site sepsis leading to removal of the external fixator in patients with 
advanced HIV compared to those with either early HIV or without HIV. This study 
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provides no evidence that this finding could not have been due to chance alone and 
therefore needs to be interpreted with caution. 
 It is possible that in this group with advanced HIV and severe open fractures, that 
delayed healing puts increasing stress through the bone pin interface. This will place 
the pin sites at risk of infection, in a patient who is also significantly 
immunocomprimised.  
 This data does not suggest that external fixation is inappropriate for severe open 
fractures in patients with advanced HIV, if these fractures were treated with internal 
fixation it is possible that they may be at higher risk of developing deep infection. It 
does suggest that if the treatment is to be external fixation then techniques which 
allow the pins to remain in situ for longer without the breakdown of the bone pin 
interface may be appropriate. Possible techniques which have been shown to 
improve the bone pin interface would be the use of hydroxyapatite coated pins or the 
concurrent administration of alendronate204,205.  
 
 
 
4.3 Comparison with previous published literature 
Table 4-1 shows a comparison of the data presented in this thesis and previous 
studies regarding wound infection in open fractures. 
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Table 4-1 
 
  Infection No Infection  The risk of developing a wound 
infection given HIV infection. 
 
Obrien
128
 
 
HIV positive 3 
(100) 
0 
(0) 
 
RR= 15(2.3-99) )
95% CI
  
P value
FE
= 0.04 
 
 
HIV negative 1 
(7) 
14 
(93) 
Paiement
5
 
HIV positive 4 
(31) 
9 
(69) 
 
RR= 3.04 (1.1-8.5) )
95% CI
  
P value
FE
= 0.06 
 
 
HIV negative 9 
(10) 
80 
(90) 
Harrison
3
 
HIV positive 5 
(42) 
7 
(58) 
 
RR = 3.75 (1.1-13.2))
95% CI 
P value 
FE
= 0.08 
 
 
HIV negative 3 
(11) 
24 
(89) 
Aird 
HIV positive 5 
(15) 
28 
(85) 
 
RR = 0.69 (0.3-1.7) )
95% CI
  
P value
X
 = 0.4 
 
 
HIV negative 19 
(22) 
67 
(78) 
 
 
Our data differs significantly from all other studies, both in numbers of patients 
and in outcome. This study has three times the number of patients of any of the 
previous studies, and is the only study not to show an increase in the risk of wound 
infection. Although all three studies are looking at the same outcome, the inclusion 
criteria vary significantly, and no study has included a marker of the severity of HIV. 
Although the work by Harrison et al has included CD4 counts, the small number of 
patients has prevented statistical analysis being performed. Paiement et al5 were 
looking at any procedure that required surgical debridement, whereas Harrison 
included many patients who were undergoing repeat operations for previously 
infected non-union’s. The grades of injuries have not been described in any of the 
previous studies. The findings from this study in patients with advanced HIV and 
those with grade 1 fractures show similarities to the findings of the previous studies. 
It is possible that the patients seen by departments in Malawi and San Francisco 
have had more advanced disease, less severe injuries or the patient management 
may have differed to that conducted in this study. 
In summary, this study has shown that in patients who are HIV positive prior to 
sustaining an open fracture, the infection rate is higher in patients with a low CD4 
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count. The data suggests a strong effect, but only weak evidence that this 
observation is not due to chance alone. The data is consistent with previous studies 
and there is biologically plausible explanation for this finding. 
It has also shown that patients who are HIV positive prior to sustaining a Grade 1 
open fracture have an increase in risk of infection. This effect is more dramatic in 
advanced HIV infection. The data suggests a strong association. The findings are 
compatible with previous similar studies and are biologically plausible. 
It is therefore likely that advanced HIV is a risk factor for wound infection, but 
early HIV does not appear to significantly affect infection rates. 
 
4.3.1 Non Union 
Harrison et al are the only group to have looked at bony union  in HIV positive 
patients with severe open tibia fractures treated with external fixation (with early 
removal of frame and then plaster). He noted an increase in the rate of non union in 
the HIV cohort. A comparison of his results and the results from this study are shown 
in Table 4-2 
Table 4-2 
 
  Non Union Union  The risk of developing a wound 
infection given HIV infection. 
 
Harrison131 
HIV positive 3 
(42) 
4 
(58) 
 
Risk Ratio = 7.3 (0/92-58))
95% CI 
P value 
FE
= 0.059 
 
 
HIV negative 1 
(6) 
16 
(94) 
Aird 
HIV positive 5,  
(15) 
28,  
(85) 
Risk ratio = 4.1 (1.1-16.3)
95%CI
  
P value
 x
= 0.04  
 
HIV negative 3,  
(4) 
79,  
(96) 
Aird 
 
Gd2 and 3 
Tibial 
Fractures 
only 
HIV positive 2,  
(33) 
4,  
(67) 
Risk ratio = 3.7 (0.64-20)
95%CI
  
P value
 x
= 0.19 
 
HIV negative 2,  
(9) 
20  
(91) 
 
Whilst the two studies have similar findings, the higher rate of non union in 
Harrison’s study can be attributed to its selection criteria of only open tibia fractures. 
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When selecting only severe open tibial fractures treated with surgical stabilization 
from the data in presented in this thesis, the non-union rates are comparable. 
Harrison only managed his patients in external fixators until the soft tissues permitted 
the use of  a plaster cast. This method may be sub-optimal for achieving bony union. 
In summary, this study has shown that when HIV infection is present at the time 
of an open fracture there is a strong association with an increased risk of non union. 
The data has been unable to show a dose related response (in relation to advanced 
CD4 count). There are a variety of plausible biological mechanisms for how this 
might occur, but little previous data to compare with. 
It is therefore likely that HIV infection is a risk factor for non union. 
It is not possible to say whether this risk is increased or reduced in patients with 
advanced HIV. 
4.3.2 Pin Site Sepsis 
 
Pin site sepsis has been previously studied by Norrish et al whose work 
suggested that there was a higher risk of severe pin site sepsis in externally fixed 
open fractures in HIV positive than in negative patients. Whilst the results for the HIV 
positive patients are very similar, the rate of pin site sepsis is much lower in the HIV 
negative patients from this study as summarized in Table 4-3.  
Table 4-3 
 The difference in results seen between these two studies may be a result of the 
difference in recording technique as discussed in section 1.3.3.7 and a difference in 
the duration of use of the external fixation. The longer the external fixator is insitu for 
the more likely it is to develop a pin site infection. Doubling the length of time is likely 
to more than double the rate of infection as there are a variety of factors 
  Checketts 
score >=2 
(%) 
Mean lenth of 
Ex-Fix (weeks) 
The risk of a pin site infection (>=2) given 
HIV infection 
Norrish
6
 HIV infection Yes No  
 
HIV positive 
9/15 
(60) 
6/15 
(40) 
8.3 
Risk Ratio = 3.6(1.6-7.95)
95% CI
 
P value
FE
=0.0023 
 
 
HIV negative 
7/35 
 (20) 
28/35 
(8) 
7.5 
 
 
 
Risk Ratio = 0.9 (0.5-1.6)
95% CI
 
P value
FE
= 1 
 
 
Aird 
HIV Positive 
6/10  
(60) 
4/10  
(40) 
15 
 
HIV negative 
14/21 
 (67) 
7/21  
(33) 
16 
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predisposing to infection, including bacterial contamination, skin necrosis from 
dressings and a deterioration in the bone pin/wire interface. It is likely that this factor 
accounts for the difference seen in the HIV negative patients pin site infection rate. It 
is surprising therefore that the HIV positive patients pin site infection rate is so 
similar, when you would expect them to be much higher in our study as the frames 
had been on for twice as long. It is possible that the difference in recording technique 
meant our pin site infection was lower, as in patients with multiple pin site infections; 
we only scored the most severe, whereas Norrish et al used each pin site as a 
separate data entry point. If patients who were HIV positive were more likely to get 
multiple pin site infections this would account for the differences. 
In summary this study has shown that when advanced HIV infection is present at 
the time of injury it is associated with a 2 fold increase in severe pin site infection. It 
has not demonstrated a dose dependant response. The data lacks power and the 
observation may be due to chance alone. There are a variety of plausible biological 
mechanisms for this observation, and the findings are compatible with the previous 
similar trial. 
It is therefore not possible to infer a causal relationship between HIV or advanced 
HIV and pin site sepsis. 
 
 
4.4 The Significance of the results 
The data from this thesis suggest that early HIV is not a significant risk factor for 
wound infection, and therefore these patients should not have their treatment altered 
as a result of concerns over increased infection rates. It is possible that these 
patients have delayed/impaired bone healing and management strategies need 
provide the best possible environment for bone healing to occur.  
Advanced HIV does appear to confer an increased risk of infection in this study 
population, and it is therefore be wise to treat these patients with some caution when 
considering internal fixation in a severe open fracture. If the skills and equipment are 
available, an appropriate external fixation device would appear to be a good 
alternative in these patients. 
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The data presented in this thesis suggests that grade 1 injuries in HIV positive 
patients would fare better with urgent debridement. It may be appropriate that in 
grade 1 open fractures, HIV positive and negative patients should be treated 
differently, with grade1 injuries in HIV positive patients being treated as a though 
they had a more severe grade of injury. This hypothesis needs to be tested further 
with a RCT.   
Many hospitals are currently amending their departmental protocols following the 
BOA/BAPRAS43 open fracture guidelines which suggest that open fractures do not 
require urgent debridement at night. It would be the author’s suggestion that 
patients, who are immuno-compromised due to HIV or other systemic conditions, 
should be prioritised for urgent debridement as soon as the appropriate 
skills/personnel are available.  
Recent data has also suggested that some open fractures may benefit from early 
thorough debridement followed by immediate primary wound closure68. The author 
would suggest that primary wound closure, whilst possibly appropriate in patients 
with early HIV, should be approached with caution in advanced HIV due to the 
increased rate of wound infection seen. 
The length of use of prophylactic antibiotics remains controversial, but guidelines 
are now suggesting shorter courses. The data presented in this thesis are unable to 
guide practice on the use of prophylactic antibiotics in HIV positive patients. It is the 
author’s opinion that until further evidence becomes available prophylactic antibiotics 
should be the same in HIV positive and negative patients   
The data from this thesis would suggest that external fixators can be used safely 
in patients with HIV. Pin site infection may be a problem, but in most cases it settled 
with antibiotics. It is the author’s view that whilst external fixation is a good option for 
the treatment of severe open fractures, the use of internal fixation should not be 
excluded.  
4.4.1 Future work 
A meta-analysis of this thesis with previously published work by Harrison et al, 
might give greater statistical power to the results. 
 Further clinical studies are required to look at union rates in HIV positive patients 
with high risk fractures. These studies should attempt to quantify time to radiological 
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and clinical union, for different types of fractures in the HIV positive and negative 
patients. To detect a 10% difference in the rate of delayed union, a study would 
require 80 HIV positive patients and 240 HIV negative patients.  
 
A clinical RCT looking at a direct comparison of externally fixed and internally 
fixed grade 2 and 3 tibia fractures would also be helpful in planning surgical 
treatment. A power calculation using 95% confidence and 80% power a non union 
rate 25-35% and a 10% difference in union rates between the methods would require 
681 HIV negative patients and 182 HIV positive patients. Given that this is a 
relatively uncommon injury, this would require a multicentre trial. 
Experimental studies looking at how the fracture environment is altered on both a 
cellular and molecular level by HIV status, CD4 level, and HAART medication, would 
help provide insight into how HIV effects wound and fracture healing 
 
4.4.2 Concluding remarks 
In 1850 open fractures had a mortality of 33%, with a poor functional prognosis 
even in those who healed. In the1980’s the HIV epidemic was spreading across the 
world and had an expected mortality of 100%. Huge advances have been made in 
these two devastating conditions. Understanding of how HIV interacts with fracture 
healing however is still in its infancy. This thesis provides some insight to guide both 
future research, and operative management in these complex and controversial 
conditions. 
The author hopes that the evidence provided in this thesis may contribute to a 
significant shift in the management of open fractures in patients with HIV. This will 
hopefully lead to this already disadvantaged population getting more appropriate 
treatment in these severe injuries.  
 
On the basis of the evidence presented, the management of open fractures in 
HIV positive patients should focus on obtaining fracture union, and should not be 
governed by the unproven fear of sepsis.  
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5   Appendix  
5.1 Statistical analysis 
Epi Info is available as freeware from www.cdc.gov/epiinfo 
5.2 Diagnostics 
Abbott Diagnostic OraQuick Rapid HIV-1/2 Diagnostic Test – This test is available 
to purchase from a variety of web sites, for institutional purchases please contact  
Abbott Diagnostics 
Abbott House 
Vanwall Business Park 
Vanwall Road 
Maidenhead, Berkshire 
SL6 4XF England 
Telephone: 01628 784041 
Fax: 01628 644205 
 
EUROTUBO is manufactured by Deltalab, they can be contacted through their 
web site on http://www.deltalab.es/ 
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